TWI238819B - Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds - Google Patents

Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds Download PDF

Info

Publication number
TWI238819B
TWI238819B TW90133244A TW90133244A TWI238819B TW I238819 B TWI238819 B TW I238819B TW 90133244 A TW90133244 A TW 90133244A TW 90133244 A TW90133244 A TW 90133244A TW I238819 B TWI238819 B TW I238819B
Authority
TW
Taiwan
Prior art keywords
compound
cns
irlalbl
paper size
acac
Prior art date
Application number
TW90133244A
Other languages
Chinese (zh)
Inventor
Viacheslav A Petrov
Ying Wang
Vladimir Grushin
Original Assignee
Du Pont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/879,014 external-priority patent/US20020121638A1/en
Application filed by Du Pont filed Critical Du Pont
Application granted granted Critical
Publication of TWI238819B publication Critical patent/TWI238819B/en

Links

Landscapes

  • Electroluminescent Light Sources (AREA)

Abstract

The present invention is generally directed to electroluminescent Ir(III) compounds, the substituted 2-phenylpyridines, phenylpyrimidines, and phenylquinolines that are used to make the Ir(III) compounds, and devices that are made with the Ir(III) compounds.

Description

1238819 A7 B7 五、發明説明(彳) 相關申請案 本申請案係現提出中請之於2GG1年6月12日提出 國專利申請案序號G9/879,G14的部分延續申請案,二年 於2000年6月30日拉山由)主々' ’、 浪 乃Μ曰桎出申印之吳國臨時申請案序號 6〇/215,362之權利,及主張於2_年8月1()日提出申請之υ 美國臨時申請案序號60/224,273之權利。 月 發明背景 發明範嘻 本發明“關於具氟化苯基σ比淀、苯基嘴咬、及苯基峻琳 之銥(III)的電發光錯合物。其亦關於其中之活性層包括電 發光Ir(III)錯合物之電子裝置。 相關技藝說明 發射光的有機電子裝置,諸如組成顯示器的發光二極 體’存在於許多不同種類的電子設備中。在所有此等裝置 中,將一有機活性層夹於兩電接觸層之間。至少一電接觸 層為光透射,以致光可通過電接觸層。當在電接觸層之兩 端施加電力時,有機活性層透過光透射電接觸層發射光。 熟知將有機電發光化合物使用作為發光二極體中之活性 成份。已知簡單的有機分子諸如蒽、噻二唑衍生物、及薰 草素衍生物會顯現電發光。半導電性共軛聚合物亦被使用 作為電發光成份,如揭示於,例如,Friend等人之美國專 利5,247,190、Heeger等人之美國專利5,408,109、及 Nakano等人之公告歐洲專利申請案443 861。具三價金屬 離子(尤其係鋁)之8-羥基喳啉根之錯合物被廣泛地使用作為 -4- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1238819 A7 B7 五、發明説明(2 電發光成份,如揭示於,例如,Tang等人之美國專利 5,552,678 °1238819 A7 B7 V. Description of the invention (彳) Related applications This application is currently being filed and requested to be filed on June 12, 2GG1. National patent application serial number G9 / 879, part of the continuation application for G14, two years in 2000. On June 30, 2014, Lashan You), the principal 々 ', and Lang Nai M said that they had the right to apply for Wu Guo ’s provisional application serial number 60 / 215,362, and claimed to apply on August 1 (), 2_ Υ Right to US Provisional Application Serial No. 60 / 224,273. Background of the Invention Invention of the invention Fan Hei The present invention "is about an electroluminescent complex with a fluorinated phenyl sigma lake, a phenyl mouth bite, and a phenyl iridium (III) iridium. It also relates to an active layer including an electrode Electronic devices that emit Ir (III) complexes. Related Art Description Organic electronic devices that emit light, such as the light-emitting diodes that make up a display, exist in many different kinds of electronic equipment. In all of these devices, one The organic active layer is sandwiched between two electrical contact layers. At least one electrical contact layer is light transmissive so that light can pass through the electrical contact layer. When power is applied to both ends of the electrical contact layer, the organic active layer transmits the light through the electrical contact layer Emission of light. It is well known to use organic electroluminescent compounds as active ingredients in light emitting diodes. It is known that simple organic molecules such as anthracene, thiadiazole derivatives, and humulin derivatives will exhibit electroluminescence. Conjugated polymers have also been used as electroluminescent components, as disclosed in, for example, US Patent No. 5,247,190 to Friend et al., US Patent No. 5,408,109 to Heeger et al., And Nakano et al. Continent patent application 443 861. The complex of 8-hydroxyphosphonium with trivalent metal ions (especially aluminum) is widely used as -4- This paper size applies to China National Standard (CNS) A4 specification (210 X 297 mm) 1238819 A7 B7 V. Description of the invention (2 Electroluminescent component, as disclosed in, for example, US Patent 5,552,678 to Tang et al.

Burrows及Thompson發表可將面(fac)_參(2-苯基吡啶) 錶使用作為有機光發射裝置中之活性成份。(^[以?/.尸/2少^ LWi. 1999,75,4。)當於主導電性材料中存在銥化合物 時,性能經最大化。Thompson更發表其中之活性層為經摻 雜面-參[2-(4,,5’-二氟苯基)吡啶-C'2,N]銥(III)之聚(N-乙 烯基咔唑)的裝置。(Polymer Preprints 2000,41(1), 770 ° ) 然而,仍持續需要具有改良效率的電發光化合物。 發明概要 本發明係關於一種具有至少兩2 -苯基σ比咬配位子之銀化 合物(一般稱為”Ιγ(ΙΙΙ)化合物”),其中在配位子上具有至少 一個氟或氟化基團。銥化合物具有以下的第一化學式··Burrows and Thompson have published that they can use the surface (fac) _ginseng (2-phenylpyridine) watch as an active ingredient in organic light emitting devices. (^ [To? /. Corpse / 2 less ^ LWi. 1999, 75, 4.) When the iridium compound is present in the main conductive material, the performance is maximized. Thompson also announced that the active layer is a poly (N-vinylcarbazole) doped surface-[[(2,4,5'-difluorophenyl) pyridine-C'2, N] iridium (III) )installation. (Polymer Preprints 2000, 41 (1), 770 °) However, there is a continuing need for electroluminescent compounds with improved efficiency. SUMMARY OF THE INVENTION The present invention relates to a silver compound (commonly referred to as a "Iγ (III) compound") having at least two 2-phenylσ specific bite ligands, wherein the ligand has at least one fluorine or fluorinated group group. The iridium compound has the following first chemical formula ...

IrLaLbLcxL,yL”z (第一化學式) 其中: X = 0或1,y = 0、1或2,及Z = 0或1,其限制條 件為: X = 0或y+z = 0及 當y = 2時,則z = 0 ; L =雙牙團配位子或單牙團配位子,且其不為苯美 °比啶、苯基嘧啶、或苯基喳啉;其限制條件 當為單牙團配位子時,y + z == 2,及 -5- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1238819 A7 B7 五、發明説明(3 當L1為雙牙團配位子時,z = 〇 ; L"=單牙團配位子,且其不為苯基_、及苯基鳴 咬、或苯基Ρ奎琳;及 L 、L及Lc係彼此相似或不同,且各La、Lb&LC 具有以下之結構(I):IrLaLbLcxL, yL "z (first chemical formula) where: X = 0 or 1, y = 0, 1 or 2, and Z = 0 or 1, the restrictions are: X = 0 or y + z = 0 and when y = 2, then z = 0; L = double- or single-group ligand, and it is not benzylpyridine, phenylpyrimidine, or phenylpyridinium; For monodentate ligands, y + z == 2 and -5- This paper size applies Chinese National Standard (CNS) A4 (210 X 297 mm) 1238819 A7 B7 V. Description of the invention (3 When L1 is For double-group ligands, z = 〇; L " = single-group ligands, and it is not a phenyl group, a phenyl group bite, or a phenyl group quinine; and L, L, and Lc are Similar to or different from each other, and each La, Lb & LC has the following structure (I):

其中: 1至114及R5至h之相鄰對可結合形成五或六員 環, R!至R8之至少一者係選自F、CnF2n + i、 〇CnF2n+1、及〇CF2X,其中n為自丨至6之整數, 及X = Η、C1、或Br,及 A - C或N,其限制條件為當a = n時,沒有r i。 在另一具體實施例中,本發明係關於用以製得以上之 Ir(III)化合物的經取代2-笨基。比·:定、苯基喊咬、及苯基p奎琳 先質化合物。先質化合物具有以下之結構(11)或(111):Wherein: adjacent pairs of 1 to 114 and R5 to h can be combined to form a five- or six-membered ring, and at least one of R! To R8 is selected from F, CnF2n + i, 〇CnF2n + 1, and 〇CF2X, where n Is an integer from 丨 to 6, and X = Η, C1, or Br, and A-C or N, and the restriction is that when a = n, there is no ri. In another embodiment, the present invention relates to substituted 2-benzyl groups used to make the above Ir (III) compounds. Ratio: Phenyl, phenyl squeak, and phenyl p-quelin precursor compounds. The precursor compound has the structure (11) or (111):

(Π) -6- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1238819 A7 B7 五、發明説明(4 ) 其中A及1至义8係如以上之結構(I)所定義, 及R9為Η。(Π) -6- This paper size applies the Chinese National Standard (CNS) A4 specification (210 X 297 mm) 1238819 A7 B7 V. Description of the invention (4) Wherein A and 1 to 8 are structured as above (I) And R9 is Η.

Rl4 其中:Rl4 where:

Rio至Ri9之至少一者係選自F、CnF2n+l、 OCnF2n + i、及OCF2X,其中η =在1及6之間的整數, 及X為Η、C1、或Br,及R2〇為Η。 當明瞭對於苯基比啶、苯基-嘧啶及苯基-喹啉鍵存在自 由旋轉。然而,關於文中之論述,將以一個定向說明化合 物。 在另一具體實施例中,本發明係關於一種具有至少一包 含以上之Ir(III)化合物、或以上之Ir(III)化合物之組合之發 射層的有機電子裝置。 此處所使用之術語”化合物”係指由分子(其係進一步由原 子所組成)所組成的未帶電物質,其中原子無法利用物理方 式分離。術語”配位子”係指附接至金屬離子之配位層的分 子、離子、或原子。術語’’錯合物"當以名詞使用時,其係 指具有至少一金屬離子及至少一配位子之化合物。術語”基 團”係指化合物的一部分,諸如有機化合物中之取代基或錯 合物中之配位子。術語”面”係指具有八面形體之錯合物 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1238819 A7 B7 五、發明説明At least one of Rio to Ri9 is selected from F, CnF2n + 1, OCnF2n + i, and OCF2X, where η = an integer between 1 and 6, and X is Η, C1, or Br, and R2O is 2 . It is clear that free rotation exists for phenylpyridine, phenyl-pyrimidine and phenyl-quinoline bonds. However, with regard to the discussion in the text, the compounds will be explained in a specific direction. In another specific embodiment, the present invention relates to an organic electronic device having at least one emitting layer including the above Ir (III) compound, or a combination of the above Ir (III) compounds. As used herein, the term "compound" refers to an uncharged substance composed of molecules, which are further composed of atoms, in which atoms cannot be physically separated. The term "ligand" refers to a molecule, ion, or atom attached to the coordination layer of a metal ion. The term 'complex', when used as a noun, refers to a compound having at least one metal ion and at least one ligand. The term "group" refers to a part of a compound, such as a substituent in an organic compound or a ligand in a complex. The term "face" refers to a complex with an octahedron. The size of this paper applies to the Chinese National Standard (CNS) A4 (210 X 297 mm) 1238819 A7 B7 V. Description of the invention

Ma^3的一異構物,其中三個”a”基團皆相鄰,即在八面體 之一面的角落。術語,,子午(meridional)”係指具有八面形體 之錯合物Ma^3的一異構物,其中三個” a,,基團佔據使其中 兩基團彼此為反式的三個位置。當使用片語,,相鄰”於指示 裝置中之層時,其並不一定係指一層與另一層緊鄰。另一 方面,使用片語”相鄰的R基團,,於指示在化學式中彼此緊靠 的R基團(即在由鍵所結合之原子上的尺基團)。術語,,光活性 係才a任何展現電發光及/或感光性之材料。術語,,(H + f),,係 才曰氫及氟之所有組合,包括完全氫化、部分氟化或全氟化 取代基。所謂,,發射最大值”係指得到最大電發光強度之以 耄微米為單位的波長。電發光一般係於二極體結構中測 量’其中將待測試材料夾於兩電接觸層之間並施加電壓。 光強度及波長可例如,分別利用光電二極體及攝譜儀測 量0 圖式說明 圖1係光發射裝置(LED)之示意圖。 圖2係LED測試裝置之示意圖。 較_佳具體實施例註沭 本發明之Ir(III)化合物具有以上的第一化學式 Ir(III)LaLbLcxL,y。 以上的Ιγ(ΙΠ)化合物經常被稱為環金屬化錯合物:具有以 下第二化學式之Ir(III)化合物亦經常被稱為雙環金屬化錯合 物: -8 - 本紙張尺度適用中國國家標準(CNS) Α4規格(210 X 297公釐) 1238819 A7 B7 五 發明説明 (第二化學式)An isomer of Ma ^ 3, in which the three "a" groups are adjacent, that is, at the corner of one face of the octahedron. The term, "meridional" refers to an isomer of the octahedral complex Ma ^ 3, three of which are "a", and the group occupies three positions in which two groups are trans to each other . When using the phrase, “adjacent” to a layer in an indicating device does not necessarily mean that one layer is in close proximity to another. On the other hand, using the phrase “adjacent R group, is in an indication in the chemical formula. The R groups next to each other (ie, the ruler group on the atom bound by the bond). In the term, photoactive is any material that exhibits electroluminescence and / or photosensitivity. The term, (H + f), refers to all combinations of hydrogen and fluorine, including fully hydrogenated, partially fluorinated or perfluorinated substituents. The so-called "emission maximum value" refers to the wavelength in units of micrometers to obtain the maximum electroluminescence intensity. Electroluminescence is generally measured in a diode structure where the material to be tested is sandwiched between two electrical contact layers and applied Voltage. Light intensity and wavelength can be measured, for example, using photodiodes and spectrographs, respectively. 0 Schematic illustration of the schematic diagram of the light emitting device (LED) in Figure 1. Figure 2 is the schematic diagram of the LED test device. Example Note: The Ir (III) compound of the present invention has the above first chemical formula Ir (III) LaLbLcxL, y. The above Iγ (ΙΠ) compound is often referred to as a cyclometallation complex: Ir having the following second chemical formula (III) Compounds are also often referred to as bicyclic metallization complexes: -8-This paper size applies Chinese National Standard (CNS) A4 specifications (210 X 297 mm) 1238819 A7 B7 Five invention descriptions (second chemical formula)

IrLaLbL,yL,,z 其中: y 、 z 、 La所定義。IrLaLbL, yL ,, z where: y, z, La are defined.

L 係如以上的第_化學式 具有以下第三化學 化錯合物: 式之Ir(III)化合物亦經常被稱為參環金屬 irL L L (第三化學式) 其中:L is the _ chemical formula of the above having the following third chemical complex: The compound of the formula Ir (III) is also often referred to as the ring metal irL L L (third chemical formula) where:

La、Lb及L。係如以上所說明之第一化學式所 義。 較佳的環金屬化錯合物為中性及非離子性,且可原封不 動地昇華。經由真空沉積製得之此等材料的薄膜展現良好 至優異的電發光性質。將氟取代基引入於銥原子上之配位 子中可使錯合物之安定性及揮發性兩者提高。結果,可在 較低之溫度下進行真空沉積,且可避免錯合物之分解。將 氟取代基引入至配位子中通常可使非輻射衰變速率及固態 中之自淬滅(self-quenching)現象降低。此等降低會導致增 進的發光效率。具供電子及拉電子性質之取代基的變化可 微調化合物之電發光性質,因此而可使電發光裝置中之亮 度及效率最適化。 雖然不以理論為基礎,但咸信自銀化合物之發射係以配 位子為基礎,由金屬至配位子之電荷轉移所產生。因此, -9- 本紙張尺度適用中國國家標準(CNS) A4規格(21〇x 297公釐) 1238819 A7 B7 五、發明説明 可展現電發光之化合物包括以上第二化學式IrLaLbL,vL”zi 化合物及以上第二化學式IrLaLbLc之化合物,其中第三化 學式中之所有·的La、Lb、及Le皆為苯基吡啶、苯基嘧啶、 或笨基喹琳。結構(I)及(π)之1^至反8基團、及以上結構(ΙΠ) 之Rio至R19基團可選自有機化合物之習知之取代基,諸如 烷基、烷氧基、鹵素、硝基、及氰基、以及氟基、氟化烷 基及氟化烧氧基。此基團可經部分或完全氟化(全氟化)。較 佳的銥化合物具有所有的反1至118及111()至1119取代基皆選自 氟基、全氟化烷基(CnF2n + 1)及全氟化烷氧基(〇CnF2n + i), 其中全氟化烧基及烧氧基具有自1至6個碳原子,或化學式 OCF2X之基團,其中X為Η、C1、或Br。 頃發現當1至反8及R10SRl9基團之任何一者或多者為硝 基時,環金屬化銥錯合物之電發光性質較差。因此,心至 Rs及尺㈠至!^9基團皆不為硝基較佳。 頃發現環金屬化銥錯合物之發光效率可經由使用苯基吡 啶、苯基嘧啶、及苯基喳啉配位子(其中一些或全部的氫經 氘取代)而改良。 含氮環可為吡啶環、嘧啶或喳啉。至少一個氟化取代基 係在含氮環上較佳;CF3最佳。 過渡金屬配位化學已知之任何習知之配位子皆適合作壯, 及L配位子。雙牙團配位子之例子包括具有兩個配位基之 化合物,諸如乙二胺及乙醯丙酮根’其可經取代。陰離子 雙牙團配位子之例子包括卜烯醇根,諸如乙酿㈣根;經 基峻淋之陰離子形式’諸如8_羥基喹啉,其可經取代,立 -10- 衣紙張尺度適用中國國豕標準(CNS) A4規格(210 X 297公爱) ~ ------- 1238819La, Lb and L. It has the meaning of the first chemical formula described above. The preferred cyclometallated complexes are neutral and non-ionic and can be sublimated intact. Thin films of these materials made by vacuum deposition exhibit good to excellent electroluminescent properties. The introduction of a fluorine substituent into a ligand on the iridium atom can improve both the stability and volatility of the complex. As a result, vacuum deposition can be performed at a lower temperature, and decomposition of the complex can be avoided. The introduction of a fluorine substituent into a ligand usually reduces the non-radiative decay rate and self-quenching in the solid state. These reductions will lead to increased luminous efficiency. Changes in the substituents with electron donating and electron-drawing properties can fine-tune the electroluminescence properties of the compound, and therefore the brightness and efficiency in the electroluminescence device can be optimized. Although it is not based on theory, the emission from the silver compound is based on the ligand and is generated by the charge transfer from the metal to the ligand. Therefore, -9- This paper size applies Chinese National Standard (CNS) A4 (21 × 297 mm) 1238819 A7 B7 V. Description of the invention The compounds that can exhibit electroluminescence include the compounds of the second chemical formula IrLaLbL, vL ”zi and The compound of the second chemical formula IrLaLbLc above, wherein all of La, Lb, and Le in the third chemical formula are phenylpyridine, phenylpyrimidine, or benzylquinine. Structures (I) and (π) 1 ^ The groups R to R 19 to the trans 8 group and the above structure (III) may be selected from conventional substituents of organic compounds such as alkyl, alkoxy, halogen, nitro, and cyano, and fluoro, Fluorinated alkyl and fluorinated alkoxy. This group can be partially or fully fluorinated (perfluorinated). Preferred iridium compounds have all trans 1 to 118 and 111 () to 1119 substituents selected from Fluoro, perfluorinated alkyl (CnF2n + 1) and perfluorinated alkoxy (0CnF2n + i), where perfluorinated alkynyl and alkoxyl have from 1 to 6 carbon atoms, or of the chemical formula OCF2X Group, where X is fluorene, C1, or Br. It is found that when any one or more of the groups 1 to 8 and R10SR19 are nitrate At the same time, the electroluminescence properties of the cyclometalated iridium complex are poor. Therefore, it is better that the radicals to Rs and ㈠ to! ^ 9 are not nitro groups. It is found that the luminous efficiency of the cyclometallated iridium complex can be Improved by the use of phenylpyridine, phenylpyrimidine, and phenylphosphonium ligands, some or all of which is replaced by deuterium. The nitrogen-containing ring can be a pyridine ring, pyrimidine, or pyrimiline. At least one fluorinated substitution The base system is preferably on a nitrogen-containing ring; CF3 is the best. Any conventional ligand known in transition metal coordination chemistry is suitable for strong and L ligands. Examples of bidentate ligands include having two Ligand compounds, such as ethylenediamine and acetone acetone, which may be substituted. Examples of anionic bidentate ligands include butenol, such as acetamidine; anionic forms via base Such as 8_hydroxyquinoline, which can be substituted, and the size of -10- paper is applicable to China National Standard (CNS) A4 (210 X 297 public love) ~ ------- 1238819

五、發明説明(8 中來自I基之奪取;胺基竣酸根;亞胺基羧酸根,諸如 σ比錢酸根;水揚St根;柳駿亞胺,諸如2_[(苯亞胺基)甲 ;及膦基烧氧化物,諸如3仁苯鱗基)+丙氧化物。 單牙團配位子之例子包括氣化物及石肖酸根離子,·鱗;異 腈,一氧化奴,及單胺。銥錯合物為中性及可昇華較佳。 如使用單-的雙?子,則其應具有]之靜電荷。如 使用兩個單牙團配位子,則其應具有-1之結合靜電荷。雙 環金屬化錯合物可有用於製備其中之配位子並非完全相同 之參環金屬化錯合物。 在一較佳具體實施例中,銀化合物具有如前所述的第三 化學式IrLaLbLc。 在一更佳具體實施例中,La = Lb = Lc。如由單晶X-射線 繞射所測定’此等更佳的化合物經常展現面形體,其中配 位至銥之氮原子相對於配位至銥之碳原子為反式。此等更 佳之化合物具有以下的第四化學式: 凾_Ir(La)3 (第四化學式) 其中La具有以上的結構(I)。 化合物亦可展現其中配位至銥之兩個氮原子相對於彼此為 反式之子午形體。此等化合物具有以下的第五化學式: 子f「mer)-Ir(La)3 (第五化學式) 其中La具有以上的結構(I)。 -11 - 未紙張尺度適用中S國家標準(CNS) A4規格(210X297公釐) 1238819 A7 B7 五、發明説明(9 以上之第四化學式及第五化學式之化合物的例子示於下 表1 : 表1 化合物 A Ri r2 Rs R4 Rs R6 R? Rs 化學式 1-a C H H cf3 H H H H H 第四 l_b C H H cf3 H H H F H 第四 1-c C H H cf3 H F H H H 第四 1-d C H H H H F H H H 第四 1-e C H H cf3 H H cf3 H H 第四 1-f C H H H H H cf3 H H 第四 i-g C H H H H H H F H 第四 1-h C Cl H CF3 H H H H H 第四 1-i C H H cf3 H H H och3 H 第四 l-j C H H cf3 H H F H H 第四 1-k C H H N02 H H cf3 H H 第四 M C H H cf3 H H H ocf3 H 第四 1-m N 麵麵 cf3 H H H H F H 第四 K C H H cf3 H H och3 H H 第四 1-r C H och3 H H H H cf3 H 第四 1-s c H H H H F H F H 第四及 第五 1-t c H H cf3 H H F H F 第五 -12- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1238819 A7... B7 五、發明説明(1〇 1-u C Η Η cf3 Η F Η F Η 第五 1-ν C Η Η cf3 Η Η Η F Η 第五 以上之第二化學式IrLaLbLfyL”z之化合物的例子包括分別 具有以下之結構(IV)、(V)、(VI)、(IX)及(X)的化合物 1 -η ^ 1-〇 ^ 1 -ρ ' 1 -w及 1 _χ ^V. Description of the invention (from the capture of the I group in 8; amine group acid group; imino carboxylic acid group, such as σ bipicanoate; Shui Yang St root; Liu Jun imine, such as 2 _ [(phenylimino)) ; And phosphine oxides, such as 3 phenylbenzene scale) + propoxide. Examples of monodentate ligands include gaseous and lithosterone ions, scales; isonitrile, nitric oxide, and monoamine. Iridium complexes are neutral and sublimable. Like using single-double? , It should have an electrostatic charge of]. If two monodentate ligands are used, they should have a combined electrostatic charge of -1. Bicyclic metallization complexes can be useful for preparing reference ring metallization complexes in which the ligands are not exactly the same. In a preferred embodiment, the silver compound has the third chemical formula IrLaLbLc as described above. In a more specific embodiment, La = Lb = Lc. These better compounds, as measured by single crystal X-ray diffraction, often exhibit planar shapes in which the nitrogen atom coordinated to iridium is trans with respect to the carbon atom coordinated to iridium. These more preferred compounds have the following fourth chemical formula: 凾 _Ir (La) 3 (fourth chemical formula) wherein La has the above structure (I). The compounds may also exhibit a meridian in which the two nitrogen atoms coordinated to iridium are trans relative to each other. These compounds have the following fifth chemical formula: The element f "mer) -Ir (La) 3 (fifth chemical formula) wherein La has the above structure (I). A4 specification (210X297 mm) 1238819 A7 B7 V. Description of the invention (Examples of the compounds of the fourth and fifth chemical formula above 9 are shown in the following Table 1: Table 1 Compound A Ri r2 Rs R4 Rs R6 R? Rs Chemical formula 1 -a CHH cf3 HHHHH fourth l_b CHH cf3 HHHFH fourth 1-c CHH cf3 HFHHH fourth 1-d CHHHHFHHH fourth 1-e CHH cf3 HH cf3 HH fourth 1-f CHHHHHH cf3 HH fourth ig CHHHHHHFH fourth 1 -h C Cl H CF3 HHHHH fourth 1-i CHH cf3 HHH och3 H fourth lj CHH cf3 HHFHH fourth 1-k CHH N02 HH cf3 HH fourth MCHH cf3 HHH ocf3 H fourth 1-m N surface cf3 HHHHFH 4th KCHH cf3 HH och3 HH 4th 1-r CH och3 HHHH cf3 H 4th 1-sc HHHHFHFH 4th and 5th 1-tc HH cf3 HHFHF 5th 12- This paper standard applies Chinese National Standard (CNS) A4 Specifications (210 X 297 mm) 1238819 A7 ... B7 V. Description of the invention (1〇1-u C Η cf3 Η F Η F Η 5th 1-ν C Η Η cf3 Η Η Η F Η 5th or more Examples of the compound of the formula IrLaLbLfyL "z include compounds having the following structures (IV), (V), (VI), (IX), and (X), respectively-1 -η ^ 1-〇 ^ 1 -ρ '1 -w And 1 _χ ^

(IV)(IV)

-13- 本紙張尺度適用中國國家標準(CNS) Α4規格(210 X 297公釐) 1238819 A7 B7-13- This paper size applies to China National Standard (CNS) A4 (210 X 297 mm) 1238819 A7 B7

本紙張尺度適用中國國家標準(CNS) A4規格(210 x 297公釐) 1238819 A7 B7 12 五、發明説明 以上之第三化學式I r La Lb Lc的銀錯合物一般係由適當的經 取代2 -苯基。比咬 '苯基σ密咬、或苯基峻琳製備得。如以上 之結構(II)所示之經取代2-苯基吡啶、苯基嘧啶、及苯基喳 啉係使用經取代2-氣吡啶、2-氣嘧啶或2-氣喳啉與芳基硼 酸之鈴木偶合作用(Suzuki Coupling),而以良好至優良的 產率製備得’如說明於0· Lohse、P. Thevenin、E. Waldvogel,办”/di,1999,45-48。關於吡啶衍生物(其 中X及Y代表取代基)將此反應說明於以下的方程式(i):This paper size applies the Chinese National Standard (CNS) A4 specification (210 x 297 mm) 1238819 A7 B7 12 V. Description of the invention The silver complex of the third chemical formula I r La Lb Lc is generally replaced by the appropriate 2 -Phenyl. Than bite 'phenyl σ dense bite, or phenyl Junlin prepared. The substituted 2-phenylpyridine, phenylpyrimidine, and phenylphosphonium shown in the above structure (II) uses substituted 2-pyridine, 2-pyrimidine, or 2-pyridinoline and arylboronic acid. Suzuki Coupling, which was prepared in good to excellent yields, 'as described in 0. Lohse, P. Thevenin, E. Waldvogel, Office "/ di, 1999, 45-48. About pyridine derivatives (Where X and Y represent substituents) This reaction is illustrated in the following equation (i):

具有以上結構(II)之2 -苯基吡啶及2 -苯基嘧啶化合物之例 子示於下表2 :Examples of 2-phenylpyridine and 2-phenylpyrimidine compounds having the above structure (II) are shown in Table 2 below:

表2 化合物 A Ri R2 Rs R4 R6 R7 R8 R9 2-a C H H cf3 H F H H H H 2-b C H H cf3 H H cf3 H H H 2_c c H H no2 H H cf3 H H H 2-d c H H cf3 H H F H H H 2-e c H H cf3 H H H CH3〇 H H -15- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1238819 A7 B7 五、發明説明(13Table 2 Compound A Ri R2 Rs R4 R6 R7 R8 R9 2-a CHH cf3 HFHHHH 2-b CHH cf3 HH cf3 HHH 2_c c HH no2 HH cf3 HHH 2-dc HH cf3 HHFHHH 2-ec HH cf3 HHH CH3〇HH -15 -This paper size is in accordance with Chinese National Standard (CNS) A4 (210 X 297 mm) 1238819 A7 B7 V. Description of the invention (13

2-f C Cl H cf3 H H H H H H 2-g C H H H ch3 H H F H H 2-h N 罐 H H H H H F H H 2-i C H H cf3 H H H CF30 H H 2-j N •麵 cf3 H H F H H H H 2-k C H H cf3 H H H F H H 2-1 C cf3 H H H H H H H H 2-m c Cl H cf3 H H H F H H 2-n c cf3 H H H H H F H H 2-0 c cf3 H H H H H CH30 H H >p c Cl H cf3 H H H CH30 H H 2-q N _ cf3 H H H H F H H 2-r c Cl H cf3 H H H H H F 2-s c H H cf3 H H H H H H 2-t c Cl H H H F H H H H 2-v c H H cf3 H H CH30 H H H 2-w c H CH30 H H H H cf3 H H 2-x c H H H H H F F H H 2-y c H H cf3 H H F H F H 2-z c H H cf3 H F H F H H 2-aa c H H Br H H H Br H H 具有以上結構(III)之經取代2-苯基喹啉化合物的一例子 為化合物2 -IX ’其具有Rl7為CF3及Rio至Rl6及Rl8至R20為 -16- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1238819 A7 B7 五、發明説明(14 ) Η。 將如此製備得之2 _苯基°比淀、喊咬、及峻淋使用於合成 環金屬化銥錯合物。已發展出使用市售之水合三氣化銥及 三氟乙酸銀之便利的單步驟方法。反應一般係不使用溶 劑,在3當量之AgOCOCF3之存Λ下,利用過量的2-苯基吡 啶、嘧啶、或喹啉進行。關於2-苯基吡啶將此反應說明於 以下的方程式(2):2-f C Cl H cf3 HHHHHH 2-g CHHH ch3 HHFHH 2-h N tank HHHHHFHH 2-i CHH cf3 HHH CF30 HH 2-j N • face cf3 HHFHHHH 2-k CHH cf3 HHHFHH 2-1 C cf3 HHHHHHHH 2- mc Cl H cf3 HHHFHH 2-nc cf3 HHHHHFHH 2-0 c cf3 HHHHH CH30 HH > pc Cl H cf3 HHH CH30 HH 2-q N _ cf3 HHHHFHH 2-rc Cl H cf3 HHHHHF 2-sc HH cf3 HHHHHH 2-tc Cl HHHFHHHH 2-vc HH cf3 HH CH30 HHH 2-wc H CH30 HHHH cf3 HH 2-xc HHHHHFFFFHH 2-yc HH cf3 HHFHFH 2-zc HH cf3 HFHFHH 2-aa c HH Br HHH Br HH has the above structure (III) An example of a substituted 2-phenylquinoline compound is Compound 2 -IX 'which has Rl7 as CF3 and Rio to R16 and R18 to R20 as -16- This paper size applies Chinese National Standard (CNS) A4 specifications (210 X 297 mm) 1238819 A7 B7 V. Description of the invention (14) Η. The 2-phenyl group prepared in this way is used to synthesize a cyclometalated iridium complex. A convenient one-step process has been developed using commercially available trihydrated iridium hydrate and silver trifluoroacetate. The reaction is generally carried out without using a solvent, and in the presence of 3 equivalents of AgOCOCF3, using an excess of 2-phenylpyridine, pyrimidine, or quinoline. This reaction for 2-phenylpyridine is illustrated by the following equation (2):

將參環金屬化銥錯合物分離,純化,及利用元素分析、4 及19F NMR光譜數據、及關於化合物1:土、l^c. ^及l-e之單 晶X-射線繞射完全定性。在一些情況中,製得異構物的混 合物。通常可使用混合物,而不將個別的異構物分離。 在一些情況中,可將具有以上之第二化學式IrLaLbL’yL’’z 之銥錯合物自使用與製備具有以上之第三化學式IrLaLbLe 之錯合物相同之合成步驟的反應混合物分離。錯合物亦可 經由先製備具有以下之結構(VII)的中間銥二聚物而製備 得: 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1238819 A7 B7 五、發明説明(The ring-ring metalized iridium complex was separated, purified, and fully characterized using elemental analysis, 4 and 19F NMR spectral data, and single crystal X-ray diffraction for compound 1: soil, l ^ c. ^, And l-e. In some cases, a mixture of isomers is made. Mixtures can often be used without separating the individual isomers. In some cases, the iridium complex having the above second chemical formula IrLaLbL'yL''z can be separated from the reaction mixture using the same synthetic step as the preparation of the complex having the third chemical formula IrLaLbLe above. The complex can also be prepared by first preparing an intermediate iridium dimer with the following structure (VII): This paper size applies the Chinese National Standard (CNS) A4 specification (210 X 297 mm) 1238819 A7 B7 V. Invention Description (

其中: B 二 Η、CH3、或C2H5,及 La、Lb、Lc、及Ld可彼此相同或不同,且各 La、Lb、Lc、及1/具有以上的結構(I)。 銥二聚物一般可經由先使水合三氯化銥與2-苯基吡啶、 苯基嘧啶或苯基喹啉反應,及加入NaOB而製備得。 一特別有用的銥二聚物為具有以下之結構(VIII)的羥基銥 二聚物:Wherein: B Η, CH3, or C2H5, and La, Lb, Lc, and Ld may be the same or different from each other, and each of La, Lb, Lc, and 1 / has the above structure (I). Iridium dimers are generally prepared by first reacting hydrated iridium trichloride with 2-phenylpyridine, phenylpyrimidine or phenylquinoline, and adding NaOB. A particularly useful iridium dimer is a hydroxyiridium dimer having the structure (VIII):

可使用此中間產物,經由加入乙醯乙酸乙酯而製備化合 物 1 - p ° 特別重要者為在橙紅色之自570至625毫微米及紅色之自 625至700毫微米之可見光譜的紅色區域中具有最大發射值 之錯合物。頃發現當L具有衍生自具有以上結構(III)之苯基 喹啉化合物之以下之結構(XI)時,或當L具有衍生自苯基異 4啉化合物之以下之結構(XII)時,第二及第三化學式之錯 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1238819 A7 B7 五、發明説明(16 合物的發射最大值移位至紅色:This intermediate can be used to prepare compound 1 by the addition of ethyl acetate-p ° Particularly important are the red regions of the visible spectrum from orange-red from 570 to 625 nm and red from 625 to 700 nm Complex with maximum emission. It was found that when L has a structure (XI) below derived from a phenylquinoline compound having the above structure (III), or when L has a structure (XII) below derived from a phenyliso4-line compound The paper size of the second and third chemical formula is in accordance with the Chinese National Standard (CNS) A4 (210 X 297 mm) 1238819 A7 B7 V. Description of the invention (The emission maximum of the 16 compound is shifted to red:

其中: R10至R19之至少一者係選自F、CnF2n+1、 〇CnF2n + 1、及OCF2X,其中η為自1至6之整 數,及X為Η、C1、或Br ;Wherein: at least one of R10 to R19 is selected from F, CnF2n + 1, 0CnF2n + 1, and OCF2X, where η is an integer from 1 to 6, and X is 及, C1, or Br;

其中: 尺2 1至R3 0之至少一者係選自F、CnF2n+l、 〇CnF2n+1、及OCF2X,其中η為自1至6之整 數,及X為Η、C1、或Br。 亦經發現本發明之配位子可具有至多12個碳原子之全氟 烷基及全氟烷氧取代基。 在第二化學式中,錯合物中之L’及L”配位子可選自以上 -19- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1238819 A7 B7 __ _ 五、發明説明(17 ) 所列之任何配位子,及將其選擇成使整體的分子不帶電較 佳。z為0,及L’係不為苯基吡啶、苯基嘧啶、或苯基喹啉 的單陰離子性雙牙團配位子較佳。 雖然並不佳,但當L為具有以上結構(I)之苯基吡啶配位 子,及L’為雙牙團羥基喳啉根配位子時,第二化學式之錯 合物亦具有移位至紅色的發射最大值。 第二化學式(其中La係與Lb相同,L’為雙牙團配位子,y 為1,及z為0)之化合物,及第三化學式(其中La、Lb、及Le 係相同)之化合物的例子示於下表8。當L具有以上之結構(I) 時,八為(:。在此表中,、〇&(:”代表2,4-戊二酮根;”81^” 代表8-羥基喹啉根;”Me-8hq”代表2-曱基-8-羥基峻啉根。 表8 化合物 錯合物化學式 配位子結構 R取代基 L, 8-a 第二 I r3 = cf3 r7 = f Me-8hq 8_b 第二 I r3 = cf3 r7 = f 8hq 8-c 第二 XI r18 = cf3 acac 8-d 第二 XII R29 ~ CF3 acac 8-e 第二 XII R28 = cf3 acac 8-f 第二 XII R29 = F acac 8-g 第二 XII R27 = F R29 = F acac -20- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1238819 A7 B7 五、發明説明(18 8-h 第二 XII R27 二 F acac R29 =F R30 二 F 8-i 第二 XII R28 二 F acac R29 =F R30 二 F 8-j 第二 XII R28 =F acac R30 =F 8-k 第二 XII R29 ~ CgFi7 acac 8-1 第三 XII R29 二 :cf3 嶋 8_m 第三 XII R28 =F - R29 二 F R30 =F 8-n 第三 XII R27 =F - R29 =F R30 =F 8-0 第三 XII R27 =F - R29 =F 8-p 第三 XII R28 ~ :cf3 _ 8_q 第三 XII R28 =F - R30 =F 8_r 第二 XII ^27 =F acac R:29 =F 8-s 资一 弟-- XII R29 = OCF3 acac -21 - 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1238819 A7 B7 五、發明説明(19 ) 表8中之錯合物具有在约590至55〇毫微米之範圍内的發射 最大值。 此外’特別重要者為在自約450至500毫微米之可見光譜 的藍色區域中具有最大發射值之錯合物。頃發現當錯合物 具有第二化學式(其中La及Lb為具有選自膦、異腈、及一氧 化碳之額外配位子之苯基吡啶配位子)時,錯合物之光致發 光及電發光移位至藍色。適當的錯合物具有以下的第六化 學式:Wherein, at least one of the feet 21 to R3 0 is selected from the group consisting of F, CnF2n + 1, 0CnF2n + 1, and OCF2X, where η is an integer from 1 to 6, and X is Η, C1, or Br. It has also been found that the ligands of the present invention may have perfluoroalkyl and perfluoroalkoxy substituents of up to 12 carbon atoms. In the second chemical formula, the L 'and L "ligands in the complex can be selected from the above -19- This paper size applies the Chinese National Standard (CNS) A4 specification (210 X 297 mm) 1238819 A7 B7 __ _ V. Any of the ligands listed in the description of the invention (17), and it is better to choose the ligand so that the entire molecule is not charged. Z is 0, and L 'is not phenylpyridine, phenylpyrimidine, or phenyl The monoanionic bidentate ligand of quinoline is preferred. Although it is not good, when L is a phenylpyridine ligand having the above structure (I), and L 'is a bidentate hydroxypyridinate ligand At the position, the complex of the second chemical formula also has an emission maximum shifted to red. The second chemical formula (where La is the same as Lb, L 'is a bidentate ligand, y is 1, and z is Examples of compounds of 0) and compounds of the third chemical formula (where La, Lb, and Le are the same) are shown in Table 8 below. When L has the above structure (I), eight is (:. In this table ,, 〇 & (: "represents 2,4-pentanedione;" 81 ^ "represents 8-hydroxyquinolinate;" Me-8hq "represents 2-fluorenyl-8-hydroxyaqualine. Table 8 Compound Chemical structure of the complex compound R substituent L, 8-a Second I r3 = cf3 r7 = f Me-8hq 8_b Second I r3 = cf3 r7 = f 8hq 8-c second XI r18 = cf3 acac 8 -d Second XII R29 ~ CF3 acac 8-e Second XII R28 = cf3 acac 8-f Second XII R29 = F acac 8-g Second XII R27 = F R29 = F acac -20- This paper is for China National Standard (CNS) A4 specification (210 X 297 mm) 1238819 A7 B7 V. Description of invention (18 8-h second XII R27 two F acac R29 = F R30 two F 8-i second XII R28 two F acac R29 = F R30 two F 8-j second XII R28 = F acac R30 = F 8-k second XII R29 ~ CgFi7 acac 8-1 third XII R29 two: cf3 嶋 8_m third XII R28 = F-R29 two F R30 = F 8-n Third XII R27 = F-R29 = F R30 = F 8-0 Third XII R27 = F-R29 = F 8-p Third XII R28 ~: cf3 _ 8_q Third XII R28 = F -R30 = F 8_r Second XII ^ 27 = F acac R: 29 = F 8-s Ziyidi-XII R29 = OCF3 acac -21-This paper size applies to China National Standard (CNS) A4 (210 X 297 Mm) 1238819 A7 B7 five Description (19) of the invention in Table 8 complexes having an emission maximum in the range of from about 590 nm to the 55〇. In addition, 'particularly important is a complex having a maximum emission value in the blue region of the visible spectrum from about 450 to 500 nm. It was found that when the complex has a second chemical formula (where La and Lb are phenylpyridine ligands having an additional ligand selected from phosphine, isonitrile, and carbon monoxide), the photoluminescence and electrical properties of the complex Luminescence shifted to blue. A suitable complex has the following sixth chemical formula:

IrLaLbL’L” (第六化學式) 其中 L ’係選自膦、異腈、及一氧化碳;IrLaLbL'L "(sixth chemical formula) wherein L 'is selected from the group consisting of phosphine, isonitrile, and carbon monoxide;

L”係選自F、C卜Br、及IL "is selected from F, C, Br, and I

La&Lb係相似或不同,且各La&Lb具有以上之結 構⑴,其中: 心至!^係分別選自烷基、烷氧基、鹵素、 硝基、氰基、氟基、氟化烷基及氟化 烷氧基,及1至118之至少一者係選自 F、CnF2n+1、〇cnF2n+1、及〇CF2X, 其中η為自1至6之整數,及χ為η、 Cl 、或Br ,及 A為C。 第六化學式中之膦配位子以具有以下的第七化學式較佳 -22- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐)---- 1238819 A7 B7 五、發明説明(20 ) P(Ar)3 (第七化學式) 其中Ar為芳基,以苯基較佳,其可具有烷基或芳基取代 基。ΑΓ基團為具有至少一氟或氟化烷基取代基之苯基最 佳。適當之膦配位子的例子包括(括號中為簡寫)·· 三苯膦[PPh3] 參[3,5-雙(三氟曱基)苯基]膦[?加?113] 一些膦化合物可於市面購得,或其可使用許多熟知合成步 驟之任何一者製備得,諸如PC13或其他P-親電子劑與有機 鋰或有機鎂化合物之烷化或芳化反應。 第六化學式中之異腈配位子以具有在芳基上之異腈取代 基較佳。適當之異腈配位子的例子包括(括號中為簡寫): 異氰2,6-二甲苯[NC-1] 異氰3-三氟曱苯[NC-2] 異氰4-甲苯磺醯甲烷[NC-3] 一些異腈化合物可於市面購得。其亦可使用已知之步驟, 諸如霍夫曼(Hofmann)反應(其中在第一胺之存在下自氣仿 及鹼產生二氣化碳烯)製備得。 第六化學式中之L”為氣化物較佳。La係與Lb相同較佳。 第六化學式(其中La係與Lb相同及L”為氯化物)之化合物 的例子示於下表9,其中1至118係如以上的結構(I)所示。 _23,, 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1238819 A7 B7 五、發明説明(21 表9La & Lb is similar or different, and each La & Lb has the above structure ⑴, where: Xin to ^ is selected from alkyl, alkoxy, halogen, nitro, cyano, fluoro, and fluorinated alkyl And fluorinated alkoxy, and at least one of 1 to 118 is selected from F, CnF2n + 1, 0cnF2n + 1, and 0CF2X, where η is an integer from 1 to 6, and χ is η, Cl , Or Br, and A is C. The phosphine ligand in the sixth chemical formula is preferably the seventh chemical formula having the following -22- This paper size applies to China National Standard (CNS) A4 specifications (210 X 297 mm) ---- 1238819 A7 B7 V. Invention Explanation (20) P (Ar) 3 (seventh chemical formula) wherein Ar is an aryl group, preferably a phenyl group, which may have an alkyl group or an aryl substituent. The AΓ group is preferably a phenyl group having at least one fluorine or fluorinated alkyl substituent. Examples of suitable phosphine ligands include (abbreviated in parentheses) ... Triphenylphosphine [PPh3] See [3,5-bis (trifluorofluorenyl) phenyl] phosphine [? 113] Some phosphine compounds are commercially available, or they can be prepared using any of a number of well-known synthetic procedures, such as the alkylation or aromatization of PC13 or other P-electrophile with organolithium or organomagnesium compounds. The isonitrile ligand in the sixth chemical formula preferably has an isonitrile substituent on an aryl group. Examples of suitable isonitrile ligands include (abbreviated in parentheses): isocyano 2,6-xylene [NC-1] isocyano 3-trifluorobenzene [NC-2] isocyan 4-toluenesulfonium Methane [NC-3] Some isonitrile compounds are commercially available. It can also be prepared using known procedures, such as the Hofmann reaction, in which di-gasified carbene is generated from a gas imitation and a base in the presence of a first amine. In the sixth chemical formula, L "is preferably a gaseous compound. La is preferably the same as Lb. Examples of compounds of the sixth chemical formula (where La is the same as Lb and L" is a chloride) are shown in Table 9 below, of which 1 The numbers from 118 to 118 are as shown in the above structure (I). _23 ,, This paper size applies Chinese National Standard (CNS) A4 (210 X 297 mm) 1238819 A7 B7 V. Description of invention (21 Table 9

化合物 L, Ri r2 Rs R4 Rs Rt Rs 9-a NC-1 H ch3 H H F H F H 9-b NC-1 H H ch3 H F H F H 9_c NC-1 H H H H F H F H 9-d NC-1 H H H H H cf3 H H 9-e NC-1 H ch3 H H H cf3 H H 9_f NC-1 H H cf3 H H H F H 9-g NC-1 H H cf3 H H cf3 H H 9-h NC-2 H H H H H cf3 H H 9-i NC-3 H H cf3 H H H F H 9-j PPh3 H H cf3 H H H F H 9-k PtmPh3 H H cf3 H H H F H 9-1 CO H H cf3 H H H F H NC-1 為 2,6-(CH3)2C6H3NC ; NC-2為3-CF3C6H4NC ; NC-3 為4-CH3C6H4S02CH2NC ; PPh3 為 P(C6H5)3 ;Compound L, Ri r2 Rs R4 Rs Rt Rs 9-a NC-1 H ch3 HHFHFH 9-b NC-1 HH ch3 HFHFH 9_c NC-1 HHHHFHFH 9-d NC-1 HHHHH cf3 HH 9-e NC-1 H ch3 HHH cf3 HH 9_f NC-1 HH cf3 HHHFH 9-g NC-1 HH cf3 HH cf3 HH 9-h NC-2 HHHHH cf3 HH 9-i NC-3 HH cf3 HHHFH 9-j PPh3 HH cf3 HHHFH 9-k PtmPh3 HH cf3 HHHFH 9-1 CO HH cf3 HHHFH NC-1 is 2,6- (CH3) 2C6H3NC; NC-2 is 3-CF3C6H4NC; NC-3 is 4-CH3C6H4S02CH2NC; PPh3 is P (C6H5) 3;

PtmPh3 為(Arf)3P,其中 Arf =3,5-(CF3)2C6H3。 表9中之錯合物具有在約450至550毫微米之範圍内的發射 最大值。 -24- 本紙張尺度適用中國國家標準(CNS) A4規格(210X297公釐) 1238819PtmPh3 is (Arf) 3P, where Arf = 3,5- (CF3) 2C6H3. The complexes in Table 9 have an emission maximum in the range of about 450 to 550 nm. -24- This paper size applies to China National Standard (CNS) A4 (210X297 mm) 1238819

電子裝詈 本發明亦關於一種包括設置於兩電接觸層之間之至少一 光活性層的電子裝置,其中裝置之此至少一層包括本發明 之銥錯合物。裝置經常具有額外的電洞輸送及電子輸送 層。圖1顯示一典型的結構。裝置1〇〇具有陽極層n〇及陰 極層150。鄰接於陽極者為包括電洞輸送材料之層12〇。鄰 接於陰極者為包括電子輸送材料之層丨40。在電洞輸送層與 電子輸送層之間為光活性層130。將層120、130、及140個 別及總稱為活性層。 視裝置10 0之應用而定,光活性層13 0可為經由施加電壓 而活化的光發射層(諸如在發光二極體或光發射電化學電池 中),對輻射能反應,及產生具有或不具有外加偏壓之信號 的一層材料(諸如在光檢波器中)。光檢波器之例子包括光導 電池、光電阻器、光控開關、光電晶體、及光電管、及光 電伏打電池,此等術語說明於Markus,John,Cf#及游 子物理學辭典(Electronics and Nucleonics 少J,470及476(McGraw-Hill,Inc.,1966)。 本發明之銥化合物尤其有用作為層130中之光活性材料, 或作為層140中之電子輸送材料。將本發明之銥錯合物使用 作為二極體中之光發射材料較佳。頃發現在此等應用中, 本發明之氟化化合物並不需在固態基質稀釋劑中才有效。 可將以層之總重量計,大於2 0重量百分比之银化合物直至 100重量百分比之銥化合物的層使用作為發射層。此係與非 氟化銥化合物-參(2-苯基吡啶)銥(111)(其經發現當以僅只 -25- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1238819 A7 B7 五、發明説明(23 ) 6至8重量百分比之量存在於發射層中時達到最大效率)相 對。此係降低自淬滅效應所需。在發射層中可與銥化合物 存在額外的材料。舉例來說,可存在螢光染料以改變發射 的顏色。亦可加入稀釋劑。稀釋劑可為聚合材料,諸如聚 (N-乙烯基咔唑)及聚矽烷。其亦可為小分子,諸如4,4’-N,N’-二咔唑聯苯或第三芳族胺。當使用稀釋劑時,銥化合 物一般係以小量存在,以層之總重量計,其通常低於20重 量百分比,以低於10重量百分比較佳。 在一些情況中,銥錯合物可以多於一種異構形態存在, 或可存在不同錯合物之混合物。當明瞭在以上之OLED的論 述中,術語”銥化合物’’係意指包括化合物及/或異構物之混 合物。 為獲致高效率的LED,電洞輸送材料之HOMO(最高佔用 分子執域)應與陽極之功函數配合,電子輸送材料之 LUMO(最低未佔用分子執域)應與陰極之功函數配合。材料 的化學相容性及昇華溫度亦係選擇電子及電洞輸送材料的 重要考量。 OLED中之其他層可由已知有用於此等層之任何材料製 成。陽極110係對於注射正電荷載體特別有效率的電極。其 可由,例如,含有金屬、混合金屬、合金、金屬氧化物或 混合金屬氧化物之材料製成,或其可為導電性聚合物。適 當的金屬包括第11族金屬、第4、5、及6族之金屬、及第8 至10族之過渡金屬。如陽極要為光透射,則一般使用第 12、13及14族金屬之混合金屬氧化物,諸如銦錫氧化物。 -26- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1238819 A7 __B7 五、發明説明(24 ) 在文中使用IUPAC編號系統,其中週期表中之族係自左至 右以1至18編號(CRC化學及物理手冊(CRC Handbook of Chemistry and Physics),第 81 版,2000)。陽極 1〇〇 亦可 包括有機材料諸如聚苯胺,如說明於”由可溶解導電性聚合 物製得之撓性發光二極體(Flexible light-emitting diodes made from soluble conducting polymer)” ,自 m 匀,第357卷,477-479頁(1992年6月11曰)。陽極 及陰極之至少一者應為至少部分透明,以使產生的光可被 觀察。 層120之電洞輸送材料的例子概述於,例如,Kirk_ Othmer,化學技術百科全書(Encyclopedia of Chemical Technology),第四版,第 18 卷,837-860 頁,1996,Υ·Electronic equipment The invention also relates to an electronic device comprising at least one photoactive layer disposed between two electrical contact layers, wherein at least one layer of the device comprises the iridium complex of the invention. Devices often have additional layers of hole transport and electron transport. Figure 1 shows a typical structure. The device 100 includes an anode layer no and an anode layer 150. Adjacent to the anode is a layer 120 that includes hole transport material. Adjacent to the cathode is a layer including an electron transport material. A photoactive layer 130 is provided between the hole transport layer and the electron transport layer. The layers 120, 130, and 140 are collectively referred to as an active layer. Depending on the application of the device 100, the photoactive layer 130 may be a light emitting layer activated by applying a voltage (such as in a light emitting diode or a light emitting electrochemical cell), responding to radiant energy, and producing A layer of material (such as in a photodetector) that does not have an externally biased signal. Examples of photodetectors include photoconductive cells, photoresistors, light-controlled switches, photoelectric crystals, and phototransistors, and photovoltaic cells. These terms are described in the Markus, John, Cf # and Dictionary of Physics (Electronics and Nucleonics). J, 470 and 476 (McGraw-Hill, Inc., 1966). The iridium compound of the present invention is particularly useful as a photoactive material in layer 130 or as an electron transporting material in layer 140. The iridium complex of the present invention It is better to use as a light emitting material in a diode. It has been found that in these applications, the fluorinated compound of the present invention does not need to be effective in a solid matrix diluent. It can be greater than 2 based on the total weight of the layer A layer of 0% by weight silver compound up to 100% by weight iridium compound is used as the emissive layer. This is related to the non-fluorinated iridium compound-ginseng (2-phenylpyridine) iridium (111) (which was found to -This paper size applies the Chinese National Standard (CNS) A4 specification (210 X 297 mm) 1238819 A7 B7 V. Description of the invention (23) 6 to 8% by weight in the emission layer to achieve maximum efficiency) relative. It is needed to reduce the self-quenching effect. Additional materials may be present with the iridium compound in the emitting layer. For example, a fluorescent dye may be present to change the color of the emission. A diluent may also be added. The diluent may be a polymeric material, Such as poly (N-vinylcarbazole) and polysilane. It can also be a small molecule such as 4,4'-N, N'-dicarbazole biphenyl or a third aromatic amine. When a diluent is used, Iridium compounds are generally present in small amounts, and are generally less than 20 weight percent, and preferably less than 10 weight percent, based on the total weight of the layer. In some cases, the iridium complex may exist in more than one isomeric form. Or, there may be mixtures of different complexes. When it is understood that in the above discussion of OLEDs, the term "iridium compound" means a mixture including compounds and / or isomers. In order to obtain high-efficiency LEDs, holes The HOMO (highest occupied molecular domain) of the transport material should match the work function of the anode, and the LUMO (lowest unoccupied molecular domain) of the electron transport material should match the work function of the cathode. The chemical compatibility and sublimation temperature of the material should also be matched. Select Electronics Important considerations for hole transport materials. Other layers in OLEDs can be made of any material known for these layers. The anode 110 is an electrode that is particularly efficient for injecting positive charge carriers. It can be made of, for example, metals, Mixed metal, alloy, metal oxide or mixed metal oxide material, or it may be a conductive polymer. Suitable metals include Group 11 metals, Groups 4, 5, and 6 metals, and Group 8 Transition metals from Groups 10 to 10. If the anode is to transmit light, mixed metal oxides of Groups 12, 13 and 14 metals, such as indium tin oxide, are generally used. -26- This paper applies Chinese National Standards (CNS) A4 specification (210 X 297 mm) 1238819 A7 __B7 V. Description of the invention (24) The IUPAC numbering system is used in the text, in which the family in the periodic table is numbered from 1 to 18 (CRC Handbook of Chemistry and Physics (CRC Handbook of Chemistry and Physics), 81st Edition, 2000). The anode 100 can also include organic materials such as polyaniline, as described in "Flexible light-emitting diodes made from soluble conducting polymer", , Vol. 357, pp. 477-479 (June 11, 1992). At least one of the anode and the cathode should be at least partially transparent so that the light produced can be viewed. Examples of hole-transporting materials for layer 120 are outlined in, for example, Kirk Othmer, Encyclopedia of Chemical Technology, Fourth Edition, Volume 18, pp. 837-860, 1996, Υ ·

Wang著。可使用電洞輸送分子及聚合物兩者。常用的電洞 輸送材料為:N,N’-二苯基-N,N、雙(3-甲苯基)-[ι,ι,_聯苯 基]-4,4’·二胺(TPD)、1,1-雙[(二-4_曱苯胺基)苯基]環己烷 (TAPC)、N,N、雙(4-甲苯基)-N,N’-雙(4-乙苯基)-[1,1’-(3,3’-二甲基)聯苯基]-4,4’-二胺(£丁?0)、肆-(3-曱苯基)->1,队>^,1^_2,5_苯二胺(?0八)、&-苯基-4-队]^二苯胺基苯 乙烯(TPS)、對(二乙胺基)苯甲醛二苯腙(DEH)、三苯胺 (TPA)、雙[4-(N,N-二乙胺基)-2-甲苯基](4-甲苯基)甲烷 (MPMP)、1-苯基_3_[對(二乙胺基)苯乙烯基]-5-[對(二乙 胺基)苯基]吡唑啉(PPR或DEASP) ' 1,2-反·雙(9H-咔唑-9-基)環丁烷(DCZB)、Ν,Ν,Ν’,Ν’-肆(4-甲苯基)·(1,Γ-聯苯 基)-4,4f-二胺(ΤΤΒ)、及卟琳(porphyrinic)化合物,諸如 -27- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1238819 A7 ___ B7 _ ^、發明説明(25 ) ^ ^ 酉太青銅。常用的電洞輸送聚合物為聚乙烯基咔唑、(苯曱基) 聚矽烷、及聚苯胺。亦可經由將電洞輸送分子諸如先前所 提及者,摻雜至聚合物諸如聚苯乙烯及聚碳酸酯中,而製 得電洞輸送聚合物。 層140之電子輸送材料的例子包括金屬鉗合類8•羥喹啉 (oxinoid)化合物,諸如參(8_經,奎琳)鋁(Alq3);啡琳基化 合物,諸如2,9-二甲基_4,7_二苯基-l,l〇-啡啉(DDpA)或 4,7-一苯基-i,l〇-啡琳(dpa),及。坐化合物諸如2-(4-聯苯 基)-5_(4-第三丁苯基)-1,3,4·哼二唑(PBD)及%(肛聯苯 基)-4•苯基-5-(4_第三丁苯基)_12,4_三唑(τΑΖ)。層14〇可 促進電子輸送,以及作為緩衝層或限制層,而防止激發子 在層界面之淬滅。此層促進電子移動率及降低激發子淬滅 較佳。 陰極150係對於注入電子或負電荷載體特別有效率之電 極。陰極可為任何具有較陽極低之功函數之金屬或非金 屬。陰極之材料可選自第丨族之鹼金屬(例如,u、Cs)、第 2族(鹼土)金屬、第12族金屬(包括稀土元素及鑭系、及婀 系)。可使用諸如鋁、銦、鈣、鋇、釤及鎂、以及其組合之 材料。亦可將含鋰之有機金屬化合物沉積於有機層與陰極 層之間,以降低操作電壓。 已知在有機電子裝置中具有其他層。舉例來說,在導電 性聚合物層12〇與活性層130之間可有一層(未示於圖中), 以促進正電荷輸送及/或層之能帶隙配合,或作為保護層 用。同樣地,在活性層130與陰極層15〇之間可有一額外層 -28- 26 l2388l9 A7 B7 發明說明( 示於圖中),以促進負電荷輸送及/或層之間的能帶隙配 合’或作為保護層用。可使用技藝中已知之層。此外,任 何則述之層可由兩層以上製成。或者,可將無機陽極層 110、導電性聚合物層120、活性層130、及陰極層15〇之一 些或全部表面處理,以提高電荷載體輸送效率。各成份層 之材料的選擇係經由使提供具高裝置效率之裝置的目標平 衡而決定較佳。 應瞭解各官能層可由多於一層所組成。 裝置可經由將個別層連續蒸氣沉積於適當的基材上而製 備得。可使用諸如玻璃及聚合薄膜之基材。可使用習知之 洛氣沉積技術,諸如熱蒸發、化學蒸氣沉積、及其類似技 術。或者’有機層可使用任何習知之塗布技術,自於適當 ;谷劑中之溶液或分散液塗布。一般而言,不同的層將具有 以下的厚度範圍:陽極110,5〇〇至5〇〇〇埃,以1〇〇〇至 2〇〇〇埃較佳;電洞輸送層12〇,50至1〇00埃,以2〇〇至8〇〇 埃較佳;光發射層130,10至1000埃,以1〇〇至8〇〇埃較 佳;電子輸送層140,50至1000埃,以200至800埃較佳; 陰極150,200至10000埃,以3〇〇至5〇〇〇埃較佳。裝置中 之電子·電洞再結合區之位置,及因此,裝置之發射光譜, 會受各層之相對厚度的影響。因此,應選擇電子輸送層之 厚度,以致電子-電洞再結合區係於光發射層中。層厚度之 期望比將視所使用之材料的確切性質而定。 應明瞭利用本發明之銥化合物製得之裝置的效率可經由 將裝置中之其他層最適化,而進一步地改良。舉例來說, -29- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1238819 A7 B7 五、發明説明(27 ) 可使用更有效率的陰極,諸如Ca、Ba或LiF。亦可應用形 狀基材及可導致操作電壓降低或量子效率增加之新穎的電 洞輸送材料。亦可加入額外的層,以調整各個層的能階, 及促進電發光。 本發明之銥錯合物通常為發磷光及光致發光,且其可有 用於除OLED外之應用。舉例來說,銥之有機金屬錯合物已 被使用作為氧敏感性指示劑,如生物鑑定中之發礙光指示 劑,及如催化劑。可使用雙環金屬化錯合物於合成其中之 三個配位子為相同或不同的參環金屬化錯合物。 實施例 以下的實施例說明本發明之一些特徵及優點。其係要說 明本發明,而非限制本發明。除非特別指示,否則所有的 百分比係以重量計。 實施例1 此實施例說明使用於形成銥化合物之2-苯基吡啶及2-苯 基嘧啶之製備。 所使用之一般步驟說明於0. Lohse、P. Thevenin、E. Waldvogel,,1999,45-48。在一典型的實驗 中,將200毫升之經脫氣水、20克之碳酸鉀、150毫升之 1,2-二曱氧乙烷、0.5克之Pd(PPh3)4、0.05莫耳之經取代 2-氣吡啶(喹啉或嘧啶)及0.05莫耳之經取代苯基硼酸之混合 物迴流(80-90°C)16至30小時。將所產生之反應混合物以 300毫升水稀釋,並以CH2C12(2x100毫升)萃取。將結合的有 機層於MgS04上乾燥,及利用真空將溶劑移除。利用真空分 -30- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1238819 A7 B7 五、發明説明(28 ) 餾將液體產物純化。使固體物質自己烷再結晶。經分離物 質之典型純度為>98%。起始物料、產率、新材料之熔點及 沸點示於表3。NMR數據及分析數據示於表4 3 表3 2-苯基吼啶、苯基嘧啶及苯基4啉之製備 化合物_產率(%)__滞點/mmHg(熔點)(°C) 2-s 70 2-a 72 2-b 48 —- 2-u 75 (76-78) 2-c 41 (95-96) 2-d 38 (39-40) 2-6 55 74.5/0.1 2-g 86 71-73/0.07 2-t 65 77-78/0.046 2-k 50 (38-40) 2-m 80 72-73/0.01 2-f 22 52-33/0.12 2-v 63 95-96/13 2-w 72 -31 - 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1238819 A7 B7 五、發明説明(29 2-x 35 61-62/0.095 2_y 62 (68-70) 2-z 42 66-67/0.06(58-60) 2-aa 60 表4 2 -苯基口比咬、苯基喊咬及苯基峻淋之性質 化合物 2 sBy Wang. Holes can be used to transport both molecules and polymers. Common hole transport materials are: N, N'-diphenyl-N, N, bis (3-tolyl)-[ι, ι, _biphenyl] -4,4 '· diamine (TPD) , 1,1-bis [(di-4_fluoranilino) phenyl] cyclohexane (TAPC), N, N, bis (4-tolyl) -N, N'-bis (4-ethylphenyl) )-[1,1 '-(3,3'-dimethyl) biphenyl] -4,4'-diamine (£ ?? 0),-(3- (phenyl)-> 1 , ≫ ^, 1 ^ _2,5_phenylenediamine (? 08), & -phenyl-4-team] ^ diphenylaminostyrene (TPS), p- (diethylamino) benzaldehyde Diphenylhydrazone (DEH), triphenylamine (TPA), bis [4- (N, N-diethylamino) -2-tolyl] (4-tolyl) methane (MPMP), 1-phenyl_3_ [P- (diethylamino) styryl] -5- [p- (diethylamino) phenyl] pyrazoline (PPR or DEASP) '1,2-trans · bis (9H-carbazole-9- Group) cyclobutane (DCZB), N, N, N ', N'-(4-tolyl) · (1, Γ-biphenyl) -4,4f-diamine (TTB), and porphyrin (Porphyrinic) compounds, such as -27- This paper size applies the Chinese National Standard (CNS) A4 specification (210 X 297 mm) 1238819 A7 ___ B7 _ ^, invention description (25) ^ ^ 酉 太Copper. Common hole-transporting polymers are polyvinylcarbazole, (phenylfluorenyl) polysilane, and polyaniline. Hole-transporting polymers can also be made by doping hole-transporting molecules, such as those previously mentioned, into polymers such as polystyrene and polycarbonate. Examples of the electron-transporting material of the layer 140 include metal-clamping 8 • oxinoid compounds, such as ginseng (quinine) aluminum (Alq3); phlenyl compounds, such as 2,9-dimethylformate -4,7-diphenyl-l, 10-morpholine (DDpA) or 4,7-monophenyl-i, 10-morphine (dpa), and. Compounds such as 2- (4-biphenyl) -5_ (4-tert-butylphenyl) -1,3,4 · humidazole (PBD) and% (anal biphenyl) -4 • phenyl- 5- (4-tert-butylphenyl) _12,4_triazole (τAZ). Layer 14 can promote electron transport and act as a buffer or confinement layer, while preventing the quenching of excitons at the layer interface. This layer preferably promotes electron mobility and reduces exciton quenching. The cathode 150 is an electrode that is particularly efficient for injecting electrons or negatively charged carriers. The cathode can be any metal or non-metal having a lower work function than the anode. The material of the cathode may be selected from the group of alkali metals (for example, u, Cs), group 2 (alkaline earth) metals, and group 12 metals (including rare earth elements and lanthanides, and actinides). Materials such as aluminum, indium, calcium, barium, scandium and magnesium, and combinations thereof can be used. It is also possible to deposit a lithium-containing organometallic compound between the organic layer and the cathode layer to reduce the operating voltage. It is known to have other layers in organic electronic devices. For example, there may be a layer (not shown) between the conductive polymer layer 120 and the active layer 130 to promote positive charge transport and / or band gap fit of the layer, or as a protective layer. Similarly, there may be an additional layer between the active layer 130 and the cathode layer 15-28-28-26 26l2388l9 A7 B7 Description of the invention (shown in the figure) to promote negative charge transport and / or band gap coordination between the layers 'Or as a protective layer. Layers known in the art can be used. In addition, any of the layers mentioned may be made of two or more layers. Alternatively, some or all of the inorganic anode layer 110, the conductive polymer layer 120, the active layer 130, and the cathode layer 150 may be surface-treated to improve the charge carrier transport efficiency. The choice of materials for each component layer is better determined by balancing the goal of providing a device with high device efficiency. It should be understood that each functional layer may be composed of more than one layer. The device can be prepared by successive vapor deposition of individual layers on a suitable substrate. Substrates such as glass and polymeric films can be used. Conventional gas deposition techniques such as thermal evaporation, chemical vapor deposition, and the like can be used. Alternatively, the ' organic layer may be coated from a suitable solution or dispersion in a cereal using any conventional coating technique. In general, the different layers will have the following thickness ranges: anode 110,500 to 5000 angstroms, preferably 1000 to 2000 angstroms; hole transport layer 1250, 50 to 10,000 angstroms, preferably 2000 to 800 angstroms; light-emitting layer 130, 10 to 1,000 angstroms, preferably 100 to 800 angstroms; electron transport layer 140, 50 to 1,000 angstroms, to 200 to 800 angstroms is preferred; 150, 200 to 10,000 angstroms are preferred, and 300 to 50,000 angstroms are more preferred. The position of the electron-hole recombination region in the device, and therefore the emission spectrum of the device, will be affected by the relative thickness of each layer. Therefore, the thickness of the electron-transporting layer should be selected so that the electron-hole recombination region is in the light-emitting layer. The desired ratio of layer thickness will depend on the exact nature of the materials used. It should be understood that the efficiency of a device made using the iridium compound of the present invention can be further improved by optimizing other layers in the device. For example, -29- this paper size applies Chinese National Standard (CNS) A4 (210 X 297 mm) 1238819 A7 B7 V. Description of the invention (27) More efficient cathodes such as Ca, Ba or LiF can be used . Shaped substrates and novel hole-transporting materials that can reduce operating voltage or increase quantum efficiency can also be applied. Additional layers can also be added to adjust the energy levels of each layer and promote electroluminescence. The iridium complex of the present invention is generally phosphorescent and photoluminescent, and it can be used in applications other than OLEDs. For example, organometallic complexes of iridium have been used as oxygen-sensitive indicators, such as light barrier indicators in bioassays, and as catalysts. Bicyclic metallization complexes can be used in the synthesis of three ring ligands which are the same or different reference metallization complexes. Examples The following examples illustrate some of the features and advantages of the present invention. It is intended to illustrate the invention, not to limit it. Unless otherwise indicated, all percentages are by weight. Example 1 This example illustrates the preparation of 2-phenylpyridine and 2-phenylpyrimidine used to form iridium compounds. The general procedures used are described in 0. Lohse, P. Thevenin, E. Waldvogel, 1999, 45-48. In a typical experiment, 200 ml of degassed water, 20 g of potassium carbonate, 150 ml of 1,2-dioxoethane, 0.5 g of Pd (PPh3) 4, and 0.05 mol of substituted 2- A mixture of gaspyridine (quinoline or pyrimidine) and 0.05 mol of substituted phenylboronic acid is refluxed (80-90 ° C) for 16 to 30 hours. The resulting reaction mixture was diluted with 300 ml of water and extracted with CH2C12 (2 x 100 ml). The combined organic layers were dried over MgS04 and the solvent was removed using vacuum. Use vacuum separation -30- This paper size applies Chinese National Standard (CNS) A4 (210 X 297 mm) 1238819 A7 B7 V. Description of the invention (28) Distillation purifies the liquid product. The solid material was recrystallized from alkane. The isolated substance has a typical purity of > 98%. The starting materials, yields, melting points and boiling points of the new materials are shown in Table 3. NMR data and analytical data are shown in Table 4 3 Table 3 Preparation compounds of 2-phenyl-pyridine, phenylpyrimidine, and phenyl 4-line_yield (%) __ stagnation point / mmHg (melting point) (° C) 2 -s 70 2-a 72 2-b 48 --- 2-u 75 (76-78) 2-c 41 (95-96) 2-d 38 (39-40) 2-6 55 74.5 / 0.1 2-g 86 71-73 / 0.07 2-t 65 77-78 / 0.046 2-k 50 (38-40) 2-m 80 72-73 / 0.01 2-f 22 52-33 / 0.12 2-v 63 95-96 / 13 2-w 72 -31-This paper size applies to Chinese National Standard (CNS) A4 (210 X 297 mm) 1238819 A7 B7 V. Description of the invention (29 2-x 35 61-62 / 0.095 2_y 62 (68- 70) 2-z 42 66-67 / 0.06 (58-60) 2-aa 60

1H NMR 7·48(3Η). 7.70(1 Η), 7.83(1 Η)· 7.90(2ΗΧ 8·75(1Η) NMR -62.68 純1^算) 2,a 7.19(1 Η), 7·30(1Η), 7.43(1Η), 7.98(2Η), 8.07(1 Η) 9.00(1Η) 2-b 7.58(1Η), 7.66(1Η), 7.88(1Η), 8·03(1Η). 8.23(1Η), 8.35 (1Η) 8.99(1 Η) 2-u 7.55(1Η), 7·63(1Η). 7.75(2Η), 7·89(2Η5, 8.28(2Η)· 8.38(1Η), 8·50 (1Η) -60.82 (3F,s), -116.96 (IF, m) -62.75 (3F(s), -63.10 (3F( s) 62.89 (s) C,64.50 (64.57) H.3.49 (3.59) N,6.07 (6.28) C,59.56 (59.75) Η,3·19 (2.90) N, 5.52 (5.81) C, 53.68 (53.60) H· 2.61 (2.40) N, 4.53 (4‘S1) C· 69.17 (70.33) H, 3.79 (3.66) N, 4.88 (5.12) -32- 本紙張尺度適用中國國家標準(CNS) A4規格(210 x 297公釐) 1238819 A7 B7 五、發明説明(3〇 表4 (續)分析%,實測(計算) 化合物 1HNMR 19F NMR _ 或MS (Μ ) 2-c 2-d it/. \M/ V J/ \J/ \m/ vlf L)^r rlHHHHHH HH)i^?H) 340803^ 68115 .5.6.9.135.404809 77.7.8.8,8 9 77.7.88. -62.14 (s) -62.78 (3F, s), ”112.61 (1F,m) C, 53.83 (53.73) H, 2.89 (2.61) N( 9.99 (10,44) 2-e 3.80(3H) 6.93(2H), 7.68(1 7.85(1 H), 7.96(2H). 8.82( 1H), -62.63 ⑼ C, 59.73 (59.75) H.2.86 (2.90) N? 5.70 (5.81) C. 61.66 (61.90) H, 3.95 (4.04) N, 5.53 (5.38〉 2^g 2‘70(3H) 7.10(3H), 7*48(1H), 7.60(1H)· 8.05(2H), -114.03 (m) 24 7.10(2H), 7.35(2H)f 7.96(1H), 8.78(1H), 73s).67m) 2· F13F, -6(3¾ 2-k \IJ/vl/\l—-\ny HHHH 2 13 1 /_\ 8 200 0698 A 77.8. -62,75 (3F‘s) -11149(m) 2-m HHHH 2 211 /v/v/lv/v 0 00 5 1807 7.N188. -62.63 (3F,s) -111.24(m) C, 76.56 (77.00) H.5.12 (5.30) N, 5.43 (7.50) C. 50.51 (52.17) H.1.97 (2-17) N, 5.09 (5.07) C, 60.39 (59·75),H,3.38 (2.90), N, 5.53 (5.51) C, 52.13 (52.17) H,2.16 (2.17) N, 4.85 (5.07) -33-1H NMR 7.48 (3Η). 7.70 (1Η), 7.83 (1Η) · 7.90 (2Η × 8.75 (1Η) NMR -62.68 pure 1 ^ calculate) 2, a 7.19 (1Η), 7 · 30 (1Η), 7.43 (1Η), 7.98 (2Η), 8.07 (1Η) 9.00 (1Η) 2-b 7.58 (1Η), 7.66 (1Η), 7.88 (1Η), 8.03 (1Η). 8.23 (1Η) 1Η), 8.35 (1Η) 8.99 (1Η) 2-u 7.55 (1Η), 7.63 (1Η). 7.75 (2Η), 7.89 (2Η5, 8.28 (2Η) · 8.38 (1Η), 8 · 50 (1Η) -60.82 (3F, s), -116.96 (IF, m) -62.75 (3F (s), -63.10 (3F (s) 62.89 (s) C, 64.50 (64.57) H.3.49 (3.59) N, 6.07 (6.28) C, 59.56 (59.75) Η, 3.19 (2.90) N, 5.52 (5.81) C, 53.68 (53.60) H · 2.61 (2.40) N, 4.53 (4'S1) C · 69.17 ( 70.33) H, 3.79 (3.66) N, 4.88 (5.12) -32- This paper size applies Chinese National Standard (CNS) A4 (210 x 297 mm) 1238819 A7 B7 V. Description of the invention (3 Table 4 (continued) ) Analysis%, measured (calculated) Compound 1HNMR 19F NMR _ or MS (Μ) 2-c 2-d it /. \ M / VJ / \ J / \ m / vlf L) ^ r rlHHHHHHHH) i ^? H ) 340803 ^ 68115 .5.6.9.135.404809 77.7.8.8, 8 9 77.7.88. -62.14 (s) -62.78 (3F, s), ”112.61 (1F, m) C, 53.83 (53.73) H, 2.89 ( 2.61) N (9.99 (10,44) 2-e 3.80 (3H) 6.93 (2H), 7.68 (1 7.85 (1 H), 7.96 (2H). 8.82 (1H), -62.63 ⑼ C, 59.73 (59.75) H.2.86 (2.90) N? 5.70 (5.81) C. 61.66 (61.90 ) H, 3.95 (4.04) N, 5.53 (5.38〉 2 ^ g 2'70 (3H) 7.10 (3H), 7 * 48 (1H), 7.60 (1H) · 8.05 (2H), -114.03 (m) 24 7.10 (2H), 7.35 (2H) f 7.96 (1H), 8.78 (1H), 73s) .67m) 2F13F, -6 (3¾ 2-k \ IJ / vl / \ l —- \ ny HHHH 2 13 1 / _ \ 8 200 0698 A 77.8. -62,75 (3F's) -11149 (m) 2-m HHHH 2 211 / v / v / lv / v 0 00 5 1807 7.N188. -62.63 (3F , s) -111.24 (m) C, 76.56 (77.00) H.5.12 (5.30) N, 5.43 (7.50) C. 50.51 (52.17) H.1.97 (2-17) N, 5.09 (5.07) C, 60.39 ( 59 · 75), H, 3.38 (2.90), N, 5.53 (5.51) C, 52.13 (52.17) H, 2.16 (2.17) N, 4.85 (5.07) -33-

本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1238819 A7 B7 五、發明説明( 31 ) 表4 (續) 分析%,實測(計算) 化合物 1H NMR 19F NMR 或 MS (Μ、 2-f 7.55(3H), -62.57(3) 257(Μ' c12h7f3c,n+^ 22i(M-CI) 7·77(2Η), 8.06(1 H), 8.87(1H) 2-v 3,8<3H), -62.70 ppm C, 61.66 (61,37), 6.95(1H)丨 Η, 3.98 (3.67), 7.30(1H), 7.50(1H), 7.58(1H)( 7.75(1H)f 7.90(1H), 8.87(1H) N.5.53 (5.48) 2-w 8.54 (lH,d), 8.21 (2H, d), 7.70 (2H, d), 7.24(1H, s)_ 6.82 (1H, dd), 3.91 (3H, s) 6.9 (2H, m), -63.08 (3F, s) 2-x -109.70 (1F, m), 7.18 (2Η,γπ), 7,68 (2H, m)· 7·95(1Η, m), 8.65(1H, -113.35(1F, m). 2-y m); 6.94(1 H), -62.72 ( 3F, s), 7·62(2Η), 7·82(1Η)· 8.03(1H). 8.96(1H); -109.11 (2F, m) 2-z 6.85(1 H), -62.80 (3F, S), 6.93(1H), -107.65 (IF· m), 7.80, 7.90, 8.05(3H), 8.89(1 H); -112.45(1F, m). 2-aa 7.70(3H,m), 7.85(3H, m), 7.80, 7.90, 8.85(1H,m). -34- 本紙張尺度適用中國國家標準(CNS) A4規格(210 x 297公釐) 1238819 A7 B7 五、發明説明(32 ) 實施例2 此實施例說明以上第四化學式面-Ir(La)3之銥化合物之製 備。 在一典型的實驗中,將IrCl3.nH20(;53-55% Ir)、 AgOCOCF3(每Ir 3.1當量)、2-芳基吼咬(過量)、及(非必 需之)少量水的混合物在N2中在180-195。(:(油浴)下劇烈授 拌2至8小時。以CHsCI2徹底萃取所得之混合物,直至萃取 液變無色為止。將萃取液過濾、通過石夕石管柱,而產生澄清 的黃色溶液。將此溶液蒸發得一殘留物,將其以曱醇處 理,而產生有色的結晶參環金屬化ir錯合物。將錯合物利用 過濾分離,以甲醇洗滌,於真空中乾燥,及(視需要)經由結 晶 '真空昇華、或索司勒(Soxhlet)萃取純化。產率:ι〇_ 82%。利用NMR光譜數據及元素分析將所有材料定性,並 將結果示於下表5。對此系列之三錯合物測得單晶X·射線結 構。 化合物1-b 使IrCl3 nH20(54% Ir ; 508 毫克)、2-(4_ 氟苯基)_5_三 氟甲基吡啶-化合物kk (2.20克)、AgOCOCF3(l.〇i克)、 及水(1毫升)之混合物在N2流中劇烈攪拌,同時並使溫度緩 慢(30分鐘)提升至185°C(油浴)。於在185-19〇t下2小時 後,混合物固化。使混合物冷卻至室溫。以二氣曱垸萃取 固體,直至萃取液脫色為止。將結合的二氣甲烷溶液過渡 通過短矽石管柱並蒸發。於將甲醇(50毫升)加至殘留物之 後,將燒瓶在-l〇°C下維持隔夜。將參環金屬化錯合物之黃 35- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1238819 A7 B7 五、發明説明 色沉澱物-化合物b -分離,以甲醇洗滌,並於真空中乾 燥。產率:1.07克(82%)。經由使其之溫溶液於丨,^二氯乙 烷中緩慢冷卻,而製得錯合物之χ•射線品質晶體。 化合物1 - e 使11*(:1311112〇(54%11*;5 04 毫克)、2-(3-三氟甲苯基)- 5-二氟曱基吡啶-化合物bb (1·60克)、及AgOCOCF3 (1·〇1克)之混合物在N2流中劇烈攪拌,同時並使溫度緩慢 (15分鐘)提升至192°C (油浴)。於在1 90 -1 95 °C下6小時後, 混合物固化。使混合物冷卻至室溫。將固體置於矽石管柱 上,接著以大量的二氣甲烷洗滌。於濾液蒸發後以甲醇處 理殘留物,而產生黃色固體。將固體收集,並經由於25毫 升之微型索司勒萃取器中利用二氯曱烷萃取而純化。將參 環金屬化錯合物之黃色沉殿物-化合物e —分離,以曱醇 洗滌,並於真空中乾燥。產率:0.59克(39〇/〇)。由熱12-二 氣乙烧製得錯合物之X-射線品質晶體。 化合物1-d 使 Ii*Cl3.nH20(54% Ir ; 508 毫克)' 2-(2-氟苯基)-5-三 氟甲基吡啶-化合物aa(1.53克)、及AgOCOCF3 (1·01克) 之混合物在%流中在190-195Τ:(油浴)下劇烈攪拌6小時又 15分鐘。使混合物冷卻至室溫,然後以熱it二氣乙烷萃 取。將萃取液過渡通過短石夕石管柱並蒸發。以曱醇(2〇毫升) 處理殘留物導致期望產物-化合物d -之沉澱,經由過濾 將其分離,以曱醇洗滌,並於真空中乾燥。產率:〇63克 (49%)。由二氣甲烷/曱醇製得錯合物之χ-射線品質晶體。 -36- ^紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) ( 34 ] " 1238819 A7 B7 使 IrCl3 nH20(54% Ir ; 503 毫克)、2-(4-三氟甲氧苯 基)-5-三氟甲基吡啶化合物ee (2.00克)、及Ag〇COCF3 (1.10克)之混合物在N2流中在190-195°C (油浴)下劇烈攪拌 2小時又45分鐘。使混合物冷卻至室溫,然後以二氣甲烷萃 取。將萃取液過濾通過短矽石管柱並蒸發。以甲醇(20毫升) 處理殘留物導致期望產物-化合物i -之沉澱,經由過濾、將 其分離,以曱醇洗滌,並於真空中乾燥。產率為0.86克。 另外,經由將母液蒸發,及將石油醚加至殘留物,而製得 0.27克之錯合物。總產率·· 1.13克(72%)。 化合物1-q 使 IrCl3.nH20(54% Ir ; 530 毫克)、2-(3-甲氧苯基)-5-三氟甲基吡啶(2.50克)、AgOCOCF3(1.12克)、及水(1亳 升)之混合物在Ns流中劇烈攪拌,同時並使溫度緩慢(30分 鐘)提升至185 °C (油浴)。於在】85 °C下1小時後,混合物固 化。使混合物冷卻至室溫。以二氣甲烷萃取固體,直至萃 取液脫色為止。將結合的二氣甲烷溶液過濾通過短矽石管 柱並蒸發。將殘留物以己烷洗滌,然後自1,2-二氣乙烷— 己烷再結晶(兩次)。產率:〇·30克。19F NMR(CD2C12, 20°C),5 : -63(s)。4 NMR(CD2C12,20°C),5 : 8·1(1Η), 7·9(1Η), 7.8(1Η、, 7.4(1Η), 6.6(2Η), 4.8(3Η)。由1,2-二氯乙烷/己烷製得錯合物之χ-射線品質 晶體(1,2 -二氣乙烧,己烧溶劑合物)。此面錯合物為燈色發 磷光。 -37- 本紙張尺度適用中國國家標準(CNS) Α4規格(210 X 297公爱) I2388l9 A7 __ 五、發明説明(35 ) 以類似方式製備得化合物IzA、LlC.、Lii至l-h ' 1-i至1-51、及k。在化合物Id之製備中,製得具有在R6或R8位次 之氟之異構物的混合物。 ----- _丨丨__和 _ ------ 一 _ ----------- i 表 5 化合物 分析 (計算(實測) _R (CD?Cl9, 25°C) 1-a C: 50.3 (50.1) H: 2.5(2.7) N: 4.9(4.9) Cl: 0.0 (0 2) ^H: 6.8(1H), 6.9(1H),7.0(1H)?7.8 (2H), 7.95(1H), 8.1 (1H) 19p; -63.4 1七 〇; 47.4(47.3) H: 2.0(2.1) N: 4,6 (4.4) 1H: 6.4 (1H), 675 (1H). 7.7 (1H), 7.8 (1H), 7.95 (1H), 8.05 (1H) 19F: -63.4 ($);-109.5 (ddd) 1~c C: 47,4 (47.2) H: 2.0(2.0) N: 4.6 (4,5) 1H: 6,6 (1H). 67 (1H), 6.9 (1H), 7.8 (1H), 8.0(1 H)· 8.6(1 H) 10F: ^63.5 (S);-112.8 (ddd) 1-d C: 55.9 (56.1) H: 3,0(3.2) N: 5.9(5.8) 1H: 6.6 (2H), 6.8 (1H)· 7.0 (1H)· 7.6 (1H),7.7(1H),8.4 (1H) 19p: -115.0 (ddd) 1-e C; 44.1 (43.3) H: 17(2.1) N: 3.9(3.0) 1H: 6.9 (1H), 7.1 (1H), 7.8 (1H), 8,0 (2H),8.2(1H) 19F: ^63.0 (1F),-63.4(1 F) 1-f C: 50.4(50.5) H: 2.5(2.7) N: 4.9(4,9) ^H: 6.9 (1H), 7.1 (2H), 7.6 (1H), 7.8 (1H), 7.9(1H),8.1 (1H) 1^F: -62.4 Vg C: 55.9(56.3) H: 3.0(3.2) N; 5.9(6.0) 1H; 6.4 (1H), 6.7 (1H)7 7.0 (1H), 7.6 (1H),7.7(2H)I7.9(1H) 19F: -112.6 (ddd) -38- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1238819 A7 B7 五、發明説明(36 )This paper size applies to Chinese National Standard (CNS) A4 specifications (210 X 297 mm) 1238819 A7 B7 V. Description of the invention (31) Table 4 (continued) Analysis%, measured (calculated) Compound 1H NMR 19F NMR or MS (Μ , 2-f 7.55 (3H), -62.57 (3) 257 (Μ 'c12h7f3c, n + ^ 22i (M-CI) 7.77 (2Η), 8.06 (1 H), 8.87 (1H) 2-v 3, 8 < 3H), -62.70 ppm C, 61.66 (61,37), 6.95 (1H) 丨 Η, 3.98 (3.67), 7.30 (1H), 7.50 (1H), 7.58 (1H) (7.75 (1H) f 7.90 (1H), 8.87 (1H) N.5.53 (5.48) 2-w 8.54 (lH, d), 8.21 (2H, d), 7.70 (2H, d), 7.24 (1H, s) _ 6.82 (1H, dd ), 3.91 (3H, s) 6.9 (2H, m), -63.08 (3F, s) 2-x -109.70 (1F, m), 7.18 (2Η, γπ), 7,68 (2H, m) · 7 95 (1Η, m), 8.65 (1H, -113.35 (1F, m). 2-ym); 6.94 (1 H), -62.72 (3F, s), 7.62 (2Η), 7.82 ( 1Η) 8.03 (1H). 8.96 (1H); -109.11 (2F, m) 2-z 6.85 (1 H), -62.80 (3F, S), 6.93 (1H), -107.65 (IF · m), 7.80, 7.90, 8.05 (3H), 8.89 (1 H); -112.45 (1F, m). 2-aa 7.70 (3H, m), 7.85 (3H, m), 7.80, 7.90, 8.85 (1H, m) .-34- This paper size applies to China National Standard (CNS) A4 specifications ( 210 x 297 mm) 1238819 A7 B7 V. Description of the invention (32) Example 2 This example illustrates the preparation of the above iridium compound of the fourth chemical formula-Ir (La) 3. In a typical experiment, IrCl3. A mixture of nH20 (; 53-55% Ir), AgOCOCF3 (3.1 equivalents per Ir), 2-aryl roar (excess), and (optionally) a small amount of water in N2 is 180-195. (: (Oil bath) vigorously stir for 2 to 8 hours. The resulting mixture is thoroughly extracted with CHsCI2 until the extract becomes colorless. The extract is filtered and passed through a Shixi stone column to produce a clear yellow solution. This solution was evaporated to obtain a residue, which was treated with methanol to produce a colored crystalline ginseng metallized ir complex. The complex was separated by filtration, washed with methanol, dried in vacuum, and (if necessary) ) Purified by crystalline 'vacuum sublimation, or Soxhlet extraction. Yield: 82-82%. All materials were characterized by NMR spectral data and elemental analysis, and the results are shown in Table 5 below. For this series The X-ray structure of the single crystal was measured for the three complexes. Compound 1-b made IrCl3 nH20 (54% Ir; 508 mg), 2- (4_fluorophenyl) _5_trifluoromethylpyridine-compound kk (2.20 G), AgOCOCF3 (1.0 gram), and water (1 ml) were vigorously stirred in a stream of N2, and the temperature was slowly (30 minutes) raised to 185 ° C (oil bath). After 2 hours at 190t, the mixture solidified. The mixture was allowed to cool to room temperature.固体 Extract the solids until the extract is decolorized. The combined digas methane solution is passed through a short silica column and evaporated. After adding methanol (50 ml) to the residue, place the flask at -10 ° C Keep overnight. The yellow of the ring-shaped metallized complex is 35- This paper is in accordance with Chinese National Standard (CNS) A4 (210 X 297 mm) 1238819 A7 B7 V. Description of the invention Color precipitate-compound b-separation, It was washed with methanol and dried in vacuum. Yield: 1.07 g (82%). The x-ray quality crystals of the complex were prepared by slowly cooling the warm solution in dichloroethane. Compounds 1-e make 11 * (: 1311112〇 (54% 11 *; 5 04 mg), 2- (3-trifluorotolyl)-5-difluorofluorenylpyridine-compound bb (1.60 g) And a mixture of AgOCOCF3 (1.01 g) was vigorously stirred in a stream of N2 while slowly raising the temperature (15 minutes) to 192 ° C (oil bath). At 1 90 -1 95 ° C for 6 hours After that, the mixture solidified. The mixture was allowed to cool to room temperature. The solid was placed on a silica column, and then washed with a large amount of digas methane. After evaporation of the liquid, the residue was treated with methanol to give a yellow solid. The solid was collected and purified by extraction with dichloromethane in a 25 ml micro Soissler extractor. The yellow metal complex was mixed with a yellow ring Shen Dianwu-Compound e—Isolated, washed with methanol, and dried in vacuum. Yield: 0.59 g (39/0). X-ray quality of the complex was obtained by calcination with hot 12-digas. Crystal. Compound 1-d makes Ii * Cl3.nH20 (54% Ir; 508 mg) '2- (2-fluorophenyl) -5-trifluoromethylpyridine-compound aa (1.53 g), and AgOCOCF3 (1 • 01 g) of the mixture was stirred vigorously in a% stream at 190-195 T: (oil bath) for 6 hours and 15 minutes. The mixture was allowed to cool to room temperature and was then extracted with hot it. The extract was passed through a short stone tube column and evaporated. Treatment of the residue with methanol (20 ml) resulted in the precipitation of the desired product-compound d-, which was separated by filtration, washed with methanol and dried in vacuo. Yield: 0.63 g (49%). X-ray quality crystals of complexes made from digas methane / methanol. -36- ^ Paper size applies Chinese National Standard (CNS) A4 (210 X 297 mm) (34) " 1238819 A7 B7 uses IrCl3 nH20 (54% Ir; 503 mg), 2- (4-trifluoromethyl) Oxyphenyl) -5-trifluoromethylpyridine compound ee (2.00 g) and AgOCOCF3 (1.10 g) were stirred vigorously in a N2 stream at 190-195 ° C (oil bath) for 2 hours and 45 Minutes. The mixture was allowed to cool to room temperature and then extracted with methane. The extract was filtered through a short silica column and evaporated. Treatment of the residue with methanol (20 mL) resulted in precipitation of the desired product-compound i-through filtration , It was separated, washed with methanol, and dried in vacuum. The yield was 0.86 g. In addition, 0.27 g of the complex was prepared by evaporating the mother liquor and adding petroleum ether to the residue. Total yield 1.13 g (72%). Compound 1-q makes IrCl3.nH20 (54% Ir; 530 mg), 2- (3-methoxyphenyl) -5-trifluoromethylpyridine (2.50 g), AgOCOCF3 (1.12 g), and water (1 liter) was vigorously stirred in a Ns flow while slowly raising the temperature (30 minutes) to 185 ° C (oil bath). After 1 hour at 85 ° C, the mixture was solidified. The mixture was cooled to room temperature. The solid was extracted with methane gas until the extract was discolored. The combined methane solution was filtered through a short silica column and evaporated. The residue was washed with hexane and then recrystallized (twice) from 1,2-digasethane-hexane. Yield: 0.30 g. 19F NMR (CD2C12, 20 ° C), 5: -63 (s). 4 NMR (CD2C12, 20 ° C), 5: 8.1 (1Η), 7.9 (1Η), 7.8 (1Η ,, 7.4 (1Η), 6.6 (2Η), 4.8 (3Η). Χ-ray quality crystals of complexes made from 1,2-dichloroethane / hexane (1,2-dichloroethane, hexane solvate). This complex is phosphorescent in color. -37- This paper size applies Chinese National Standard (CNS) A4 specification (210 X 297 public love) I2388l9 A7 __ 5. Description of the invention (35) Compounds IzA, LlC., Lii to lh are prepared in a similar manner 1- i to 1-51, and k. In the preparation of the compound Id, a mixture of isomers having fluorine at the R6 or R8 position is prepared. ----- _ 丨 丨 __ and _ ---- --- _ ----------- i Table 5 Compound analysis (calculated (measured) _R (CD? Cl9, 25 ° C) 1-a C: 50.3 (50.1) H: 2.5 (2.7) N: 4.9 (4.9) Cl: 0.0 (0 2) ^ H: 6.8 (1H), 6.9 (1H), 7.0 (1H)? 7.8 (2H), 7.95 (1H), 8.1 (1H) 19p; -63.4 170; 47.4 (47.3) H: 2.0 (2.1) N: 4,6 (4.4) 1H: 6.4 (1H ), 675 (1H). 7.7 (1H), 7.8 (1H), 7.95 (1H), 8.05 (1H) 19F: -63.4 ($); -109.5 (ddd) 1 ~ c C: 47,4 (47.2) H: 2.0 (2.0) N: 4.6 (4,5) 1H: 6,6 (1H). 67 (1H), 6.9 (1H), 7.8 (1H), 8.0 (1 H), 8.6 (1 H) 10F : ^ 63.5 (S); -112.8 (ddd) 1-d C: 55.9 (56.1) H: 3,0 (3.2) N: 5.9 (5.8) 1H: 6.6 (2H), 6.8 (1H) · 7.0 (1H ) · 7.6 (1H), 7.7 (1H), 8.4 (1H) 19p: -115.0 (ddd) 1-e C; 44.1 (43.3) H: 17 (2.1) N: 3.9 (3.0) 1H: 6.9 (1H) , 7.1 (1H), 7.8 (1H), 8,0 (2H), 8.2 (1H) 19F: ^ 63.0 (1F), -63.4 (1 F) 1-f C: 50.4 (50.5) H: 2.5 (2.7 ) N: 4.9 (4,9) ^ H: 6.9 (1H), 7.1 (2H), 7.6 (1H), 7.8 (1H), 7.9 (1H), 8.1 (1H) 1 ^ F: -62.4 Vg C: 55.9 (56.3) H: 3.0 (3.2) N; 5.9 (6.0) 1H; 6.4 (1H), 6.7 (1H) 7 7.0 (1H), 7.6 (1H), 7.7 (2H) I7.9 (1H) 19F: -112.6 (ddd) -38- This paper size applies to China National Standard (CNS) A4 (210 X 297 mm) 1238819 A7 B7 V. invention is described in (36)

裝 訂 表5 (續) 分析 NMR 化合物1 (計算(實測) (CD9C19, 25°〇 1-h C: 51.0(45.2) H: 2.1 (2.3) N: 4,9 (4*2) 1H: 6.8 (1H), 6.95 (1H), 7 05 (1H), 7.7 (1Η).8·0<1Η>>8‘9(1Η) -63.3 1-1 C: 49.4(49.3) H: 2.9(2.8) N: 4.4(4.4) 1H: 3.6 (3H)· 6·3 (1H), 6 6 (1H)· 7.7 (2H), 7.65(1 Η), 7.95(1 Η) 19F: -63.2 1 -j C: 47.4(47.4) H: 2.0(2.3) N: 4.6(4 7) 1Η: 6.7 (m), 7.1 (m), 7.5 (m), 7.6 (m), 1Ί (m), 8.0 (m), 8.2 (m) 19F: 8 s 諧振(-63.0 — -63.6) 及8ddd諧振(_92.2·-112 1-k C: 43.5(44.0) H: 1.8(2.1) N: 8.5(8.4) 1H: 6.9 (1H), 7.15 (1H), 8.1 (1H)r 8.3 (1H), 8.45 (1H), 8.6 (1H) 19F: -62.9 1-1 C: 42.2 (42.1) H: 16.(1.8) N: 3.8(3.7) 1H: 6.5 (1H), 6.7 (1H), 7.75 (1H), 7.85 (1H), 8.0 (1H), 8.1 (1H) 19F: -58.1 (1F), -63.4 (1F) 實施例3Binding Table 5 (continued) Analytical NMR Compound 1 (calculated (measured) (CD9C19, 25 ° 〇1-h C: 51.0 (45.2) H: 2.1 (2.3) N: 4,9 (4 * 2) 1H: 6.8 ( 1H), 6.95 (1H), 7 05 (1H), 7.7 (1Η). 8.0 < 1Η > > 8'9 (1Η) -63.3 1-1 C: 49.4 (49.3) H: 2.9 (2.8) N: 4.4 (4.4) 1H: 3.6 (3H) · 6.3 (1H), 6 6 (1H) · 7.7 (2H), 7.65 (1 Η), 7.95 (1 Η) 19F: -63.2 1 -j C : 47.4 (47.4) H: 2.0 (2.3) N: 4.6 (4 7) 1Η: 6.7 (m), 7.1 (m), 7.5 (m), 7.6 (m), 1Ί (m), 8.0 (m), 8.2 (m) 19F: 8 s resonance (-63.0 — -63.6) and 8ddd resonance (_92.2 · -112 1-k C: 43.5 (44.0) H: 1.8 (2.1) N: 8.5 (8.4) 1H: 6.9 (1H), 7.15 (1H), 8.1 (1H) r 8.3 (1H), 8.45 (1H), 8.6 (1H) 19F: -62.9 1-1 C: 42.2 (42.1) H: 16. (1.8) N: 3.8 (3.7) 1H: 6.5 (1H), 6.7 (1H), 7.75 (1H), 7.85 (1H), 8.0 (1H), 8.1 (1H) 19F: -58.1 (1F), -63.4 (1F) 3

此實施例說明以上第二化學式11*1/1^1>%1/4%之銥錯合 物的製備。 化合物1 -η 使11^1311112〇(54%11:;5 10毫克)、2-(3-三氟甲苯基)喳 啉(1.80克)、及三氟乙酸銀(1·1〇克)之混合物在190-195°C 下劇烈攪拌4小時。使所產生之固體於矽石上利用二氣甲烷 層析,而產生二環金屬化錯合物及未反應配位子之混合 物。經由以溫己烷萃取,而將未反應配位子自混合物移 除。於萃取液變無色後,將己烷不可溶解的固體收集並於 -39- 本紙張尺度適用中國國家標準(CNS) A4規格(210X 297公釐) ' " 1238819 A7 B7 五、發明説明(37 ) 真空中乾燥。產率為0.29克。19F NMR : -63.5 (s,6F)、 -76.5(s,3F)。經由單晶X-射線繞射研究而確定此錯合物之 結構。 化合物1 - 〇 $IrCl3.nH20(54% Ir ; 500 毫克)、2-(2-氟苯基)-3-氯· 5-三氟曱基吡啶(2.22克)、水(0.3毫升)、及三氟乙酸銀 (1 · 〇〇克)之混合物在1 90 °C下攪伴1 · 5小時。使固體產物於 矽石上利用二氯曱烷層析,而產生0.33克之二環金屬化水 三氟乙酸錯合物-化合物Ι-p、及未反應配位子之2:1共結 晶加成物。19F NMR ·· -63.0 (9F),-76.5 (3F), -87.7 (2F),_ 114.4 (IF)。經由自二氯曱烷-己烷再結晶, 而將共結晶的苯基吡啶配位子移除。經由單晶X-射線繞射 研究而確定加成物及錯合物之結構。 實施例4 此實施例說明具有以上結構(VIII)之羥基銥二聚物的製 備。 使11*(:1311112〇(54%11*;5 10毫克)、2-(4-氟苯基)-5-三 氟甲基处啶(725毫克)、水(5毫升)、及2-乙氧乙醇(20毫升) 之混合物在迴流下劇烈攪拌4.5小時。於加入NaOH(2.3克) 溶於水(5毫升)之溶液,隨後再加入2 0毫升水之後,使混合 物在迴流下攪拌2小時。使混合物冷卻至室溫,以50毫升水 稀釋,並過濾。使固體在迴流下與30毫升之1,2-二氣乙烷 及NaOH水溶液(2.2克溶於8毫升水)劇烈攪拌6小時。使有 機溶劑自混合物蒸發,而留下橙色固體於水相中之懸浮 -40- 本紙浪尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1238819 A7 _ B7 __ 五、發明説明(38 ) 液。經由過濾將橙色固體分離,將其以水徹底洗滌,並於 真空中乾燥,而產生0.94克(95%)之銥羥基二聚物(光譜級 純度)。4 NMR (CD2C12) ·· -1.0 (s,1H,IrOH),5.5 (dd, 2H),6.6 (dt,2H),7.7 (dd,2H),7·9 (dd,2H),8.0 (d, 2H),9· 1 (d,2H)。19F NMR (CD2C12) : -62.5 (s5 3F), 109.0 (ddd, IF)。 實施例5 此實施例說明自銥二聚物製備雙環金屬化錯合物。This example illustrates the preparation of the iridium complex of the second chemical formula 11 * 1/1 ^ 1 >% 1/4%. Compound 1-η is a compound of 11 ^ 1311112〇 (54% 11 :; 5 10 mg), 2- (3-trifluorotolyl) pyridinium (1.80 g), and silver trifluoroacetate (1.10 g). The mixture was stirred vigorously at 190-195 ° C for 4 hours. The resulting solid was chromatographed on silica using digas methane to produce a mixture of bicyclic metallization complexes and unreacted ligands. Unreacted ligands were removed from the mixture by extraction with warm hexane. After the extract turned colorless, collect the hexane-insoluble solids at -39- This paper size applies Chinese National Standard (CNS) A4 (210X 297 mm) '" 1238819 A7 B7 V. Description of the invention (37 ) Dry in vacuum. The yield was 0.29 g. 19F NMR: -63.5 (s, 6F), -76.5 (s, 3F). The structure of this complex was determined by single crystal X-ray diffraction studies. Compound 1-〇 $ IrCl3.nH20 (54% Ir; 500 mg), 2- (2-fluorophenyl) -3-chloro · 5-trifluorofluorenylpyridine (2.22 g), water (0.3 ml), and A mixture of silver trifluoroacetate (1000 g) was stirred at 1 90 ° C for 1.5 hours. The solid product was chromatographed on silica using dichloromethane to yield 0.33 g of bicyclic metallized water trifluoroacetic acid complex-compound 1-p, and a 2: 1 co-crystal adduct of unreacted ligand. . 19F NMR: -63.0 (9F), -76.5 (3F), -87.7 (2F), -114.4 (IF). The co-crystallized phenylpyridine ligand was removed via recrystallization from dichloromethane-hexane. The structure of adducts and complexes was determined by single crystal X-ray diffraction studies. Example 4 This example illustrates the preparation of a hydroxyiridium dimer having the above structure (VIII). 11 * (: 13111112 (54% 11 *; 5 10 mg), 2- (4-fluorophenyl) -5-trifluoromethylpyridine (725 mg), water (5 ml), and 2- The mixture of ethoxyethanol (20 ml) was stirred vigorously under reflux for 4.5 hours. After adding a solution of NaOH (2.3 g) in water (5 ml), and then 20 ml of water was added, the mixture was stirred under reflux for 2 Hours. The mixture was allowed to cool to room temperature, diluted with 50 ml of water, and filtered. The solid was stirred vigorously under reflux with 30 ml of 1,2-digasethane and NaOH aqueous solution (2.2 g in 8 ml of water). Hours. Allow the organic solvent to evaporate from the mixture, leaving an orange solid suspended in the water phase. -40- The standard of this paper applies the Chinese National Standard (CNS) A4 specification (210 X 297 mm) 1238819 A7 _ B7 __ V. Invention Explanation (38) liquid. The orange solid was separated by filtration, washed thoroughly with water, and dried in vacuo, yielding 0.94 g (95%) of an iridium hydroxyl dimer (spectrum-grade purity). 4 NMR (CD2C12 )--1.0 (s, 1H, IrOH), 5.5 (dd, 2H), 6.6 (dt, 2H), 7.7 (dd, 2H), 7.9 (dd, 2H), 8.0 (d, 2H), 9.1 (d, 2H). 19F NMR (CD2C12): -62.5 (s5 3F), 109.0 (ddd, IF). Example 5 This example illustrates the preparation of a bicyclic metal from an iridium dimer. Chemical complex.

化合物1-P 使實施例4之銥羥基二聚物(1 〇〇毫克)、乙醯乙酸乙酯 (0.075毫升;4倍過量)、及二氣曱烷(4毫升)之混合物在室 溫下攪拌隔夜。將溶液過濾通過短矽石塞,並蒸發而得橙 黃色固體,將其以己烷洗滌並乾燥。錯合物之產率為109毫 克(94%)。4 NMR(CD2C12) : 1.1 (t, CH3),3.9 (dm, CH2), 4.8 (s,CH3COC/〇,5.9 (m),6.7 (m),7.7 (m), 8·0 (m),8.8 (d)。19F NMR (CD2C12) : -63.1 (s,3F), -63.2 (s,3F),-109.1 (ddd,1F),-109.5 (ddd)。分析: 計算值:C,44·9; H,2·6; N,3·5。實測值:C,44.4; H, 2.6; N,3.3。 化合物1 - w 將實施例4之羥基銥二聚物(〇 20克)溶於THF(6毫升)之溶 液以5 0毫克三氟乙酸處理,過濾通過短矽石塞,蒸發至約 0.5毫升,以己烷(8毫升)處理,並留置隔夜。將黃色結晶固 體分離,以己烷洗滌,並於真空中乾燥。產率(1:1 THF溶 -41 - 木紙張尺度適用中國國家標準(CNS) Α4規格(210 X 297公釐) 1238819 A7 B7 五、發明説明(39 ) 劑合物):0.24 克(96%)。19F NMR (CD2C12,20。〇, (5 : -63.2 (s,3F), -76.4 (s,3F), -107.3 (ddd, IF)。4 NMR (CD2C12 5 20°C) 5 δ · 9.2 (br s? 1H), 8.2 (dd, 1H),8·1 (d,1H),7.7 (m,1H),6.7 (m,1H),5.8 (dd, 1H),3.7 (m,2H,THF),1.8 (m,2H,THF)。 化合物1 _ x 使二氣乙酸鹽中間產物-化合物l-w( 75毫克)、及2-(4-溴苯基)_5_溴。比啶(130毫克)之混合物在N2中在150 - 155°C 下攪拌3 0分鐘。使所產生之固體冷卻至室溫,並溶解於 <:ΓΙ2<:12中。將生成溶液過濾通過石夕膠並蒸發^將殘留物以 溫己烷洗滌數次,並於真空中乾燥,而留下黃色、黃色光 致發光固體。產率:74毫克(86%)。19F NMR (CD2C12, 20°C),ά : -63·1 (s, 3F),-63.3 (s,3F),-108.8 (ddd, 1F),-109.1 (ddd,IF)。4 NMR (CD2C12,20。〇,5 : 8.2 (s), 7·9 (m),7.7 (m),7.0 (d),6·7 (m),6.2 (dd), 6.0 (dd)。如由X-射線分析所證實,此錯合物為子午式, 氟化配位子之氮為反式。 實施例6 此實施例說明以上第五化學式f手_Ir(La)3之銀化合物的 製備。 化合物1-s 此錯合物係以與化合物類似之方式合成得。根據 NMR、TLC、及TGA數據,結果為面及子午異構物之大約 1:1的混合物。 -42- 本紙張尺度適用中國國家標準(CNS) A4規格(210X 297公爱) 1238819 A7 B7 五、發明説明(4〇 ) 化合物1-t 使 IrCl3.nH20(54% Ir ; 0.40 克)、2-(3,5-二氟苯基)-5-三氟甲基咣啶(1.40克)、AgOCOCF3(0.81克)、及水(〇·5 毫升)之混合物在N2流中劇烈攪拌,同時並使溫度缓慢ρο-βο 分鐘) 提升至 165。(:(油浴 ) 。 於在 165°C 下 40 分鐘後 ,混合 物固化。使混合物冷卻至室溫。以二氣甲烷萃取固體,直 至萃取液脫色為止。將結合的二氯甲烷溶液過濾通過短矽 石管柱並蒸發。將殘留物以己烷徹底洗滌並於真空中乾 燥。產率:0.53 克(49%)。19F NMR (CD2C12,20°C), 5 : -63.55 (s,3F),-63.57 (s,3F),-63.67 (s,3F), -89·1 (t, 1F),-100.6 (t,1F),-102.8 (dd,1F),-118.6 (ddd,1F),-119.3 (ddd,1F),.123.3 (ddd,IF)。4 NMR (CD2C12,20°c),5 : 8·4 (s),8·1 (m),7.9 (m), 7.6 (s),7.5 (m),6.6 (m),6.4 vm)。亦如由 X-射線分析所 證實,此錯合物為子午線。 化合物1 - u 此錯合物係與化合物1 -q類似地製備及分離,然後再經由 自1,2 -二氣乙烧-己烧結晶而純化。純化產物之產率為 53%。依據NMR數據,錯合物為子午。19f (CD2C12,20。〇,5 : -63.48 (s,3F),-63.52 (s,6F) -105.5 (ddd,1F),-105.9 (ddd, IF), -106.1 (ddd,lF)Compound 1-P A mixture of the iridium hydroxy dimer (1000 mg), ethyl acetate (0.075 ml; 4-fold excess), and dioxane (4 ml) of Example 4 at room temperature Stir overnight. The solution was filtered through a plug of short silica and evaporated to give an orange-yellow solid, which was washed with hexane and dried. The yield of the complex was 109 mg (94%). 4 NMR (CD2C12): 1.1 (t, CH3), 3.9 (dm, CH2), 4.8 (s, CH3COC / 〇, 5.9 (m), 6.7 (m), 7.7 (m), 8 · 0 (m), 8.8 (d). 19F NMR (CD2C12): -63.1 (s, 3F), -63.2 (s, 3F), -109.1 (ddd, 1F), -109.5 (ddd). Analysis: Calculated: C, 44 · 9; H, 2 · 6; N, 3.5. Found: C, 44.4; H, 2.6; N, 3.3. Compound 1-w The hydroxyiridium dimer of Example 4 (0 20 g) was dissolved in The THF (6 ml) solution was treated with 50 mg of trifluoroacetic acid, filtered through a short silica plug, evaporated to about 0.5 ml, treated with hexane (8 ml), and left overnight. The yellow crystalline solid was separated and separated with hexane. Wash with alkane and dry in vacuum. Yield (1: 1 THF-41-wood paper size applies Chinese National Standard (CNS) A4 specifications (210 X 297 mm) 1238819 A7 B7 V. Description of the invention (39) Compound): 0.24 g (96%). 19F NMR (CD2C12, 20.0, (5: -63.2 (s, 3F), -76.4 (s, 3F), -107.3 (ddd, IF). 4 NMR ( CD2C12 5 20 ° C) 5 δ · 9.2 (br s? 1H), 8.2 (dd, 1H), 8.1 · (d, 1H), 7.7 (m, 1H), 6.7 (m, 1H), 5.8 (dd , 1H), 3.7 (m, 2H, THF), 1.8 (m, 2H, THF). Compound 1 x x the digas acetate intermediates-compound 1w (75 mg), and 2- (4-bromophenyl) _5_bromo.pyridine ( 130 mg) of the mixture was stirred in N2 at 150-155 ° C for 30 minutes. The resulting solid was cooled to room temperature and dissolved in <: ΓΙ2 <: 12. The resulting solution was filtered through Shijiao And evaporated ^ The residue was washed several times with warm hexane and dried in vacuum, leaving a yellow, yellow photoluminescent solid. Yield: 74 mg (86%). 19F NMR (CD2C12, 20 ° C) Ά: -63 · 1 (s, 3F), -63.3 (s, 3F), -108.8 (ddd, 1F), -109.1 (ddd, IF). 4 NMR (CD2C12, 20.0, 5: 8.2 ( s), 7.9 (m), 7.7 (m), 7.0 (d), 6.7 (m), 6.2 (dd), 6.0 (dd). As confirmed by X-ray analysis, this complex is meridian and the nitrogen of the fluorinated ligand is trans. Example 6 This example illustrates the preparation of the silver compound of the fifth chemical formula f-Ir (La) 3 above. Compound 1-s This complex is synthesized in a similar manner to the compound. Based on NMR, TLC, and TGA data, the result was an approximately 1: 1 mixture of noodle and meridional isomers. -42- This paper size applies Chinese National Standard (CNS) A4 specification (210X 297 public love) 1238819 A7 B7 V. Description of the invention (4〇) Compound 1-t makes IrCl3.nH20 (54% Ir; 0.40 g), 2 A mixture of-(3,5-difluorophenyl) -5-trifluoromethylpyridine (1.40 g), AgOCOCF3 (0.81 g), and water (0.5 ml) was vigorously stirred in a N2 stream, and simultaneously Slowly increase the temperature (ρο-βο minutes) to 165. (: (Oil bath). After 40 minutes at 165 ° C, the mixture solidified. The mixture was allowed to cool to room temperature. The solid was extracted with digas methane until the extract was discolored. The combined dichloromethane solution was filtered through a short Silica column and evaporation. The residue was washed thoroughly with hexane and dried in vacuum. Yield: 0.53 g (49%). 19F NMR (CD2C12, 20 ° C), 5: -63.55 (s, 3F) , -63.57 (s, 3F), -63.67 (s, 3F), -89 · 1 (t, 1F), -100.6 (t, 1F), -102.8 (dd, 1F), -118.6 (ddd, 1F) , -119.3 (ddd, 1F), .123.3 (ddd, IF). 4 NMR (CD2C12, 20 ° c), 5: 8.4 (s), 8.1 (m), 7.9 (m), 7.6 ( s), 7.5 (m), 6.6 (m), 6.4 vm). Also as confirmed by X-ray analysis, this complex is a meridian. Compound 1-u This complex was prepared and isolated similarly to compound 1 -q, and then purified by crystallization from 1,2-digasethane-hexane. The yield of the purified product was 53%. According to the NMR data, the complex was meridian. 19f (CD2C12, 20.0, 5: -63.48 (s, 3F), -63.52 (s, 6F) -105.5 (ddd, 1F), -105.9 (ddd, IF), -106.1 (ddd, 1F)

-107.4 (t,1F),-107.9 (t,1F),-109.3 (t,IF)。咕 NMR (CD2C12 ’ 20。〇 ’ 5 : 8·6 (m),8·3 (s),8.2 (s),8·1 (m) 7.9 (m), 7.6 (m),6·6 (m),6.4 (m),6·0 (m),5.8 (m)。 -43- 本紙張尺度適用中國國家標準(CNS) A4規格(210 x 297公釐) 1238819 A7 B7 五、發明説明(41 )-107.4 (t, 1F), -107.9 (t, 1F), -109.3 (t, IF). NMR (CD2C12 '20 .〇 '5: 8.6 (m), 8.3 (s), 8.2 (s), 8.1 (m) 7.9 (m), 7.6 (m), 6.6 ( m), 6.4 (m), 6.0 · (m), 5.8 (m). -43- This paper size applies to China National Standard (CNS) A4 (210 x 297 mm) 1238819 A7 B7 V. Description of the invention ( 41)

化合物1 - V 使用三氟乙酸二環金屬化中間產物-化合物1-x、及2-(4-氟苯基)-5-三氟甲基吡啶,以與化合物1-w類似之方式 製備得此子午-錯合物。19f NMR(CD2C12,20。〇,5 : -63.30 (s,3F),-63.34 (s,3F),-63.37 (s,3F),-108.9 (ddd,1F),-109.0 (ddd,1F),-109.7 (ddd,1F)。4 NMR (CD2C12,20〇C),5 : 8.3-7.6 (m),6.7 (m),6·6 (dd),6.3 (dd),6.0 (dd)。當於1大氣壓下昇華時,此黃色 發光子午錯合物異構化成綠色發光面異構物-化合物1 - b。 實施例7 此實施例說明使用本發明之銥錯合物之OLED的形成。 利用熱蒸發技術製得包括電洞輸送層(HT層)、電發光層 (EL層)及至少一電子輸送層(E 丁層)之薄膜〇LED裝置。使 用具有油擴散泵之Edward Auto 306蒸發器。所有薄膜沉 積的基礎真空係在托爾(ton*)之範圍内。沉積室可無需 中斷真空,而沉積五個不同薄膜。 使用具有約10⑻-2000埃之ITO層的銦錫氧化物(ITO)塗 布玻璃基材。先經由利用IN HC1溶液將不必要的ITO區域 钱刻掉,將基材圖案化,而形成第一電極圖案。使用聚醯 亞胺帶材作為光罩。然後使經圖案化的ITO基材於清潔劑水 溶液中以超音波清潔。接著將基材先以蒸餾水,再以異丙 醇滌洗,然後於甲苯蒸氣中脫脂〜3小時。 然後將經清潔的圖案化ITO基材裝入至真空室中,並將室 抽真空至10·6托爾。接著使用氧電漿將基材進一步清潔約5- -44- 本紙張尺度適用中國國家橾準(CNS) A4規格(21〇x 297公釐) 1238819 A7 _____ B7___ 五、發明説明(42 ) ίο分鐘。於清潔後,接著利用煞蒸發將多層薄膜連續沉積 於基材上。最後,透過光罩沉積八丨之圖案化金屬電極。在 沉積過程中使用石英晶體監視器(Syc〇I1 STC-200)測量薄 膜之厚度。記述於實施例中之所有薄膜厚度係假設沉積材 料之密度為1而計算得的標稱厚度。接著將完成的OLED裝 置自真空室取出,並不經包封而立即定性。 表6顯示裝置層的概述及厚度。在所有情況中,陽極係如 以上所論述的IT〇,及陰極係具有在7〇〇-76〇埃之範圍内之 厚度的Α1。在一些樣品中,使用雙層電子輸送層。先指示 的層係鄰接於EL層。 表6 Alq3 =參(8-羥基喳啉)铭 1^?八=2,9-二曱基-4,7-二苯基-1,10_啡啉 fr(ppy)3 =面_參(2·苯基吡句銥 MPMP =雙[4<N,N-二乙胺基)-2-甲苯基](4-甲苯基)曱烷 樣品 HT層 (厚度,A) EL層 (厚度,A) ET層 (厚度,A) 比較 MPMP (528) Ir(ppy>3 (408) DDPA (106) + Alq3 (320) 1 MPMP (520) 化合物izfe (499) DDPA(125) + Alq3 (365) MPMP (541) 化合物1-b (580) DDPA (407) 3 — MPMP (540) 化合物1-e (499) DDPA (112)+ Alq3 (340) 4 ^ MPMP (525) 化合物1-k (406) DDPA (106) Alq3 (341) 5^^ MPMP (570) 化合物Izi (441) DDPA (107)+ Alq3 (339) -45- 本紙張尺度適用中國國家標準(CNS) Α4規格(21〇 X 297公釐) 1238819 A7 ^^_-_- 五、發明説明(43 ) 6 MPMP (545) 化合物lii (462) — DDPA(111) + Alq3(319) 7 MPMP (643) 化合物l_q (409) DDPA(112) + Alq3(361) 8 MPMP (539) 化合物M (430) DDPA(109) + Alq3(318) 9 MPMP (547) 化合物U (412) DDPA (105) + Alq3 (300) 10 MPMP (532) 化合物1-h (457) DDPA (108) + Alq3 (306) 11 MPMP (603) 化合物1-d (415) DDPA (111)+ Alq3 (303) 12 MPMP (551) 化合物 (465) DDPA (106)+ Alq3 (313) 13 MPMP (520) 化合物1:1 (405) DDPA (410) 14 MPMP (504) 化合物JL·^ (400) DDPA (393) 15 MPMP (518) 化合物ϋ (153) DDPA (418) 16 MPMP (556) 化合物1-m (416) DDPA (430) 17 MPMP (520) 化合物IrS (419) DDPA (420) 18 MPMP (511) 化合物1-0 (412) DDPA (413) 19 MPMP (527) 化合物1-p (425) DDPA (412) 20 MPMP (504) 化合物1-b (417) DPA (407) 2T^ MPMP (525) 化合物Ιζί (419) DPA (416) 22^ MPMP (520) 化合物1-u (421) DPA (405) -46 - 本紙張尺度適用中國國家標準(CNS) A4規格(210 x 297公釐) 1238819 A7 B7 五、發明説明(44 OLED樣品係經由測量其之(1)電流-電壓(I-V)曲線,(2) 電發光光度對電壓,及(3)電發光光譜對電壓而定性。圖2 顯示所使用之裝置200。利用凱斯利源測量單元(Keithley Source-Measurement Unit) 23 7 型、280 測量 OLED 樣品 220之I-V曲線。邊使用凱斯利SMU掃描電壓,邊利用 Minolta LS-110亮度計210測量電發光光度(單位燭光 (Cd)/平方米)對電壓。電發光光譜係經由使用一對透鏡230 透過電子擋閘240收集經由攝譜儀250分散之光,然後利用 二極體陣列偵檢器260測量而得。所有的三個測量係同時進 行,並利用電腦270控制。裝置在特定電壓下之效率係經由 將LED之電發光光度除以使裝置運作所需之電流密度而測 得。單位為燭光/安培。 結果示於下表7 : 表7 銥化合物之電發光性質 樣品 尖峰光度 Cd/m2 尖峰光度下 之效率 Cd/A 尖峰效率 Cd/A 大約的 尖峰波長 mn 比較 540 在22 V 0.39 0.48 522 1 1400 在21 V 3.4 11 525 2 1900 在25 V 5.9 13 525 3 830 在18V 1.7 13.5 525 4 7.6 在27 V 0.005 0.13 521 -47- 本纸張尺度適用中國國家標準(CNS) A4規格(210X 297公釐) 1238819 A7 B7 五、發明説明(45 表7 銥化合物之電發光性質 樣品 尖峰光度 Cd/m2 尖峰光度下 之效率 Cd/A 尖峰效率 Cd/A 大約的 尖峰波長 nm 5 175 在25 V 0.27 1.8 530, 563 6 514 在20 V 1.5 2.2 560 7 800 在26 V 0.57 1.9 514 8 1200 在28 V 0.61 2 517 9 400 在18 V 1.1 4 545 10 190 在16 V 2.3 3.3 575 11 1150 在25 V 1.2 3.8 506, 526 12 340 在20 V 0.49 2.1 525 13 400 在21 V 3 5 520 14 1900 5 9 525 15 2500 6 11 525 16 100 在27 V 0.17 0.2 560 17 3.5 在28 V 0.005 0.014 575 18 30 在26 V 0.08 0.16 590 19 2000 在21V 6 8 532 -48- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1238819 A7 B7 五、發明説明(46 表7 銥化合物之電發光性質 樣品 尖峰光度 Cd/m2 尖峰光度下 之效率 Cd/A 尖峰效率 Cd/A 大約的 尖峰波長 nm 20 350 在26 V 0.60 1.6 595 21 1200 在22 V 5 545 22 80 在19 V 1 540 尖峰效率係裝置中之電發光化合物之值的最佳指示。其 指示需輸入至裝置中,以得到特定數目之光子離開(光度)之 電子數目的量度。其係一基本的重要數值,其反映光發射 材料的固有效率。其對於實際的應用亦重要,由於較高的 效率意謂需要較少電子以達到相同的光度,其依序意謂較 低的功率消耗。較高效率之裝置亦傾向於具有較長壽命, 由於有較高比例的注射電子被轉變為光子,而非產生熱或 造成不期望的化學副反應。本發明之大部分的銥錯合物具 有較母面-參(2-苯基吡啶)銥錯合物高甚多的尖峰效率。如 以上所論述,該等具較低效率之錯合物亦可有用作為發磷 光或光致發光材料,或作為催化劑。 實施例8 此實施例說明具有化學式XI之配位子母化合物-1-(2,4-二氟笨基)異喳啉的製備。 使2,4-二氟苯基硼酸(Aldrich Chemical Co.,13.8 克, -49- 本紙張尺度適用中國國家標準(CNS) A4規格(210 x 297公釐) 1238819 A7 ______ B7 五、發明説明(47~) ' ' ~ 87 4 笔莫耳)、!-氣異 4 淋(Aldrich Chemical Co.,13 克 79.4愛莫耳)、肆三苯膦I巴(〇)(Aidrich,3 · 00克, 2.59¾ 莫耳)、碳酸钟(em Science,24·2 克,175 毫莫 耳)、水(300毫升)、及二甲氧乙烷(Aldrich,3〇〇毫升)在 N2中在迴流下攪拌20小時,之後使混合物冷卻至室溫,及 將有機層和水層分離。將水層以3 x 15〇毫升之乙醚萃取, 並將結合的有機部分以硫酸鈉乾燥,過濾,並將濾液蒸發 至乾。使粗製材料於矽膠管柱上層析,先以4:1己烧 /CHAl2將催化劑副產物溶離,最後再以 CH2Cl2/MeOH(9.5:0.5,產物Rf = 0.7)將產物溶離。收集 純產物部分,並將其於真空中乾燥,而得17 7克(92%分離 產率)之淡黃色固體,>95% NMR光譜純度。1H NMR (CDC13,296 Κ,300 ΜΗζ),(58.61 (1Η,d,J = 5·7 Ηζ), 7.89 (1Η,d,J = 8.2 Ηζ),7.67-7.85 (3Η,m),7·52-7.63 (2H,m),6.95-7· 12 (2H,m) ppm。19F NMR (CDC13 ,296 K ,282 MHz) 5 -109.01 (1F, brs), -109.87 (1F,d,JF_F = 8.5 Hz)。 實施例9 此實施例說明橋連二氣二聚物-[IrCl{2-(2,4-二氟苯基) 異喹啉}2]2之製備。 使實施例8之1-(2,4-二氟苯基)異喳啉(1.00克,4.15毫莫 耳)、IrCl3(H2〇)3(Strem Chemicals,703 毫克,1.98 毫 莫耳)、及2-乙氧乙醇(Aldrich Chemical Co.,25毫升)於 迴流下攪拌15小時,之後經由過濾將沉澱物分離,以甲醇 -50- 本紙張尺度適用中國國家標準(CNS) A4規格(210X 297公釐) 1238819 A7 B7 五、發明説明(48 洗務’並使其於真空中乾燥,而得1〇4克(74〇/〇)之橙紅色固 體的產物,>95% NMR光譜純度。1H NMR (CD2C12, 296 K,300 MHz) : 5 8·85 (2H,d,J = 6·4 Ηζ),8·38 (2H,dd,J = 8.8&9.5Hz),7.82-7.97 (m,4H),7.67-7.78 (2H,m),6.81 (2H,d,J : 6.4 Hz),6.42 (2H,ddd, J = 2.4,3.3,及 11·4 Hz),5.25 (2H,dd,J = 2.4及 8·8 Hz)ppm。i9F NMr (CE)Cl3,296K,282 MHz) (5-95.7 (2F,d,JF-F = 12 Hz),-108.03 (2F,d,JF_F = 12 Hz)。 實施例10 此實施例說明表8中之雙環金屬化銥錯合物一 [Ir(acac){l_(2,4-二氟苯基)異喹啉}2]—錯合物8-!*之製 備。 使實施例9之[IrCl{l-(2,4-二氟苯基)異喳啉}2]2 (300毫 克 ’ 0.212 毫莫耳)、乙醯丙酮鈉(Aldrich chemical Co., 78宅克,〇·636毫莫耳)、及2_乙氧乙醇(1()毫升)在12〇艽下 攪拌0.5小時。然後將揮發性成份在真空中移除。將殘留物 溶解於二氣甲烷中,並使此溶液通過矽膠之墊,以二氣曱 烧作為溶離溶劑。將所得之橙紅色濾液蒸發至乾,然後懸 洋於甲醇中。經由過濾將沉澱產物分離,並於真空中乾 燥。分離產率=230 毫克(70%)。4 NMR (CD2C12,296 K ’ 300 MHz) ·· 5 8·40(2Η,dd,J = 8.8 及 9 Hz),7.97 (2H,d,J = 8.1 Hz),7.78 (2H,ddd,J = 0.7, 6.6,及7·8 Hz),7.70 (2H,dd,J = 1.3 及8.4 Hz),7.66 (2H,d,J = 6.4 Hz),6.44 (2H,ddd,J = 2.4,5.9,及 1〇·8 ppm), -51 - 本紙張尺度適用中國國家標準(CNS) A4規格(21〇x 297公釐) 1238819 A7 B7 五、發明説明(49 ) 5.68(2H,dd,J = 2.4&8.5Hz),5.30(lH,s),1.78(6H, s)。19F NMR (CDC13,296K,282 ΜΗζ)5·"96·15 (2F, d,JF_F = 11·3 Ηζ),-109.13 (2F,d,JF-F = 11.3 Hz)。 使用類似的步驟製備得表8中之化合物8-a至8-k、及化合 物8-s 〇 使用實施例2之步驟製備得表8中之化合物8-1至8-q。 實施例11 使用根據實施例7之步驟製造薄膜OLED裝置。表10顯示 裝置層的概述及厚度。在所有情況中,陽極係如以上所論 述的ITO,及陰極係具有在700-760埃之範圍内之厚度的 A1 〇 表 MPMP =雙[4-(N,N_ 二乙胺 | DPA = 4,7-二 $ 10 I0-2-甲苯基](4_曱苯基)曱烷 良基-1,10-啡啉 樣品 HT層 EL層 ET層 (厚度,A) (厚度,人) (厚度,人) 11-1 MPMP 化合物8-a DPA (572) (419) (400) 11-2 MPMP 化合物8-b DPA (512) (407) (394) 11-3 MPMP 化合物8-c DPA (548) (441) (408) -52- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐)Compounds 1 to V were prepared in a similar manner to compound 1-w using the trifluoroacetic acid bicyclic metallization intermediates, compound 1-x, and 2- (4-fluorophenyl) -5-trifluoromethylpyridine. This meridian-complex. 19f NMR (CD2C12, 20.0, 5: -63.30 (s, 3F), -63.34 (s, 3F), -63.37 (s, 3F), -108.9 (ddd, 1F), -109.0 (ddd, 1F) -109.7 (ddd, 1F). 4 NMR (CD2C12, 20 ° C), 5: 8.3-7.6 (m), 6.7 (m), 6.6 (dd), 6.3 (dd), 6.0 (dd). When sublimed at 1 atmosphere, this yellow luminescent meridium complex isomerizes to a green luminescent surface isomer, Compound 1-b. Example 7 This example illustrates the formation of an OLED using the iridium complex of the present invention. A thin film including a hole transporting layer (HT layer), an electroluminescent layer (EL layer), and at least one electron transporting layer (E Ding layer) was fabricated by thermal evaporation technology. An Edward Auto 306 with an oil diffusion pump was used for evaporation. The basic vacuum for all thin film deposition is in the range of ton (ton *). The deposition chamber can deposit five different films without interrupting the vacuum. Indium tin oxide (ITO) with an ITO layer of about 10 ⑻ to 2000 angstroms ( ITO) coated glass substrate. First use unnecessary IN HC1 solution to cut away unnecessary ITO area and pattern the substrate to form the first electrode pattern. Use polyimide tape as Then, the patterned ITO substrate was ultrasonically cleaned in a detergent aqueous solution. Then the substrate was first washed with distilled water, then with isopropyl alcohol, and then degreased in toluene vapor for ~ 3 hours. The clean patterned ITO substrate is loaded into a vacuum chamber, and the chamber is evacuated to 10.6 Torr. Then the substrate is further cleaned using an oxygen plasma about 5- -44- This paper is applicable to Chinese national standards (CNS) A4 specification (21〇x 297 mm) 1238819 A7 _____ B7___ V. Description of the invention (42) Min. After cleaning, the multilayer film is then continuously deposited on the substrate by evaporation. Finally, through the photomask The patterned metal electrode was deposited on the eighth. The thickness of the film was measured using a quartz crystal monitor (SycoI1 STC-200) during the deposition process. All film thicknesses described in the examples were calculated assuming the density of the deposited material was 1. The nominal thickness obtained is then taken out of the completed OLED device from the vacuum chamber and immediately characterized without encapsulation. Table 6 shows the overview and thickness of the device layers. In all cases, the anode system is IT as discussed above. , And the cathode system has A1 having a thickness in the range of 700-76 Angstroms. In some samples, a double-layer electron transport layer is used. The layer indicated first is adjacent to the EL layer. Table 6 Alq3 = ref (8- Hydroxypyridinium) hydrazine = 2,9-difluorenyl-4,7-diphenyl-1,10_morpholine fr (ppy) 3 = noodles_seng (2 · phenylpyridine iridium MPMP = Bis [4 < N, N-diethylamino) -2-tolyl] (4-tolyl) pinane sample HT layer (thickness, A) EL layer (thickness, A) ET layer (thickness, A) Compare MPMP (528) Ir (ppy> 3 (408) DDPA (106) + Alq3 (320) 1 MPMP (520) compound izfe (499) DDPA (125) + Alq3 (365) MPMP (541) compound 1-b ( 580) DDPA (407) 3 — MPMP (540) Compound 1-e (499) DDPA (112) + Alq3 (340) 4 ^ MPMP (525) Compound 1-k (406) DDPA (106) Alq3 (341) 5 ^^ MPMP (570) compound Izi (441) DDPA (107) + Alq3 (339) -45- This paper size is applicable to China National Standard (CNS) A4 specification (21〇X 297 mm) 1238819 A7 ^^ _-_ -V. Description of the invention (43) 6 MPMP (545) compound lii (462) — DDPA (111) + Alq3 (319) 7 MPMP (643) compound l_q (409) DDPA (112) + Alq3 (361) 8 MPMP ( 539) Compound M (430) DDPA (109) + Alq3 (318) 9 MPMP (547) Compound U (412) DDPA (105) + Alq3 (300) 10 MPMP (532) Compound 1-h (457) DDPA (108) + Alq3 (306) 11 MPMP (603) Compound 1-d (415) DDPA (111) + Alq3 (303) 12 MPMP (551) Compound (465) DDPA (106) + Alq3 (313) 13 MPMP (520) Compound 1: 1 (405) DDPA (410) 14 MPMP (504) Compound JL ^ (400) DDPA (393) 15 MPMP (518) Compound ϋ (153) DDPA (418) 16 MPMP (556) Compound 1-m (416) DDPA (430) 17 MPMP (520) Compound IrS (419) DDPA (420) 18 MPMP (511) Compound 1-0 (412) DDPA (413) 19 MPMP (527) Compound 1-p (425) DDPA (412) 20 MPMP (504) Compound 1-b (417) DPA (407) 2T ^ MPMP (525) Compound Ιζί (419) DPA (416) 22 ^ MPMP (520) Compound 1-u (421) DPA (405) -46 -This paper size is in accordance with Chinese National Standard (CNS) A4 (210 x 297 mm) 1238819 A7 B7 V. Description of the invention (44 OLED samples are measured by (1) the current-voltage (IV) curve, (2) Electroluminescence photometric vs. voltage, and (3) Electroluminescence spectrum vs. voltage. Figure 2 shows the device 200 used. The Keithley Source-Measurement Unit 23 7 and 280 were used to measure the I-V curve of the OLED sample 220. While scanning voltage with Kesley SMU, use Minolta LS-110 luminance meter 210 to measure the electroluminescence luminosity (unit candle light (Cd) / m 2) versus voltage. The electroluminescence spectrum is obtained by using a pair of lenses 230 through an electronic shutter 240 to disperse the light scattered through the spectrograph 250 and then measure it with a diode array detector 260. All three measurements are performed simultaneously and controlled using a computer 270. The efficiency of a device at a particular voltage is measured by dividing the electroluminescence of the LED by the current density required to operate the device. The unit is candlelight / amp. The results are shown in Table 7 below: Table 7 Electroluminescence properties of iridium compounds Sample peak photometric efficiency Cd / m2 Peak photometric efficiency Cd / A Peak efficiency Cd / A Approximate peak wavelength mn Comparison 540 at 22 V 0.39 0.48 522 1 1400 at 21 V 3.4 11 525 2 1900 at 25 V 5.9 13 525 3 830 at 18 V 1.7 13.5 525 4 7.6 at 27 V 0.005 0.13 521 -47- This paper size applies the Chinese National Standard (CNS) A4 specification (210X 297 mm) 1238819 A7 B7 V. Description of the invention (45 Table 7 Electroluminescence properties of iridium compounds Sample peak luminosity Cd / m2 Peak efficiency Cd / A Peak efficiency Cd / A Approximate peak wavelength nm 5 175 at 25 V 0.27 1.8 530, 563 6 514 at 20 V 1.5 2.2 560 7 800 at 26 V 0.57 1.9 514 8 1200 at 28 V 0.61 2 517 9 400 at 18 V 1.1 4 545 10 190 at 16 V 2.3 3.3 575 11 1150 at 25 V 1.2 3.8 506, 526 12 340 at 20 V 0.49 2.1 525 13 400 at 21 V 3 5 520 14 1900 5 9 525 15 2500 6 11 525 16 100 at 27 V 0.17 0.2 560 17 3.5 at 28 V 0.005 0.014 575 18 30 at 26 V 0.08 0.16 590 19 2000 at 21V 6 8 532 -48- This paper size applies to China Standard (CNS) A4 specification (210 X 297 mm) 1238819 A7 B7 V. Description of invention (46 Table 7 Electroluminescence properties of iridium compounds Sample peak photometric Cd / m2 Peak photometric efficiency Cd / A Peak photometric efficiency Cd / A Approximate The peak wavelength of nm 20 350 at 26 V 0.60 1.6 595 21 1200 at 22 V 5 545 22 80 at 19 V 1 540 The peak efficiency is the best indication of the value of the electroluminescent compound in the device. Its instruction needs to be entered into the device, This is a measure of the number of electrons that a particular number of photons leave (photometric). It is a fundamentally important value that reflects the inherent efficiency of a light-emitting material. It is also important for practical applications, because higher efficiency means less electrons are needed to reach the same luminosity, which in turn means lower power consumption. Higher efficiency devices also tend to have longer lifetimes because a higher percentage of injected electrons are converted into photons rather than generating heat or causing unwanted chemical side reactions. Most of the iridium complexes of the present invention have much higher peak efficiencies than the mother-faced-ginseng (2-phenylpyridine) iridium complex. As discussed above, these less efficient complexes can also be useful as phosphorescent or photoluminescent materials, or as catalysts. Example 8 This example illustrates the preparation of the ligand parent compound of formula XI-1- (2,4-difluorobenzyl) isoxoline. Use 2,4-difluorophenylboronic acid (Aldrich Chemical Co., 13.8 g, -49-) This paper size applies to China National Standard (CNS) A4 (210 x 297 mm) 1238819 A7 ______ B7 V. Description of the invention ( 47 ~) '' ~ 87 4 Moore) ,! -Gas iso 4-leaching (Aldrich Chemical Co., 13 g 79.4 Emole), triphenylphosphine 1 bar (〇) (Aidrich, 3.0 g, 2.59¾ mole), carbonic acid bell (em Science, 24 · 2 g, 175 mmol), water (300 ml), and dimethoxyethane (Aldrich, 300 ml) were stirred under reflux in N 2 for 20 hours, after which the mixture was cooled to room temperature, and the organic The layers are separated from the water layer. The aqueous layer was extracted with 3 x 150 ml of ether, and the combined organic portions were dried over sodium sulfate, filtered, and the filtrate was evaporated to dryness. The crude material was chromatographed on a silica gel column. The catalyst by-products were first dissolved in 4: 1 hexane / CHAl2, and finally the products were dissolved in CH2Cl2 / MeOH (9.5: 0.5, product Rf = 0.7). The pure product fraction was collected and dried in vacuo to give 177 g (92% isolated yield) of a pale yellow solid with > 95% NMR spectral purity. 1H NMR (CDC13, 296 K, 300 ΜΗζ), (58.61 (1Η, d, J = 5 · 7 Ηζ), 7.89 (1Η, d, J = 8.2 Ηζ), 7.67-7.85 (3Η, m), 7. · 52-7.63 (2H, m), 6.95-7 · 12 (2H, m) ppm. 19F NMR (CDC13, 296 K, 282 MHz) 5 -109.01 (1F, brs), -109.87 (1F, d, JF_F = 8.5 Hz). Example 9 This example illustrates the preparation of a bridged digas dimer- [IrCl {2- (2,4-difluorophenyl) isoquinoline} 2] 2. Let Example 8-1 -(2,4-difluorophenyl) isoxoline (1.00 g, 4.15 mmol), IrCl3 (H2O) 3 (Strem Chemicals, 703 mg, 1.98 mmol), and 2-ethoxyethanol ( Aldrich Chemical Co. (25 ml) was stirred under reflux for 15 hours, and then the precipitate was separated by filtration, and the methanol was -50. This paper size is applicable to China National Standard (CNS) A4 (210X 297 mm) 1238819 A7 B7 5 2. Description of the invention (48 washings and drying in vacuum to obtain 104 g (74/0) of orange-red solid product, > 95% NMR spectral purity. 1H NMR (CD2C12, 296 K , 300 MHz): 5 8 · 85 (2H, d, J = 6 · 4 Ηζ), 8 · 38 (2H, dd, J = 8.8 & 9.5Hz), 7.82-7.97 (m, 4H), 7.67-7.78 (2H, m), 6.81 (2H, d, J: 6.4 Hz), 6.42 (2H, ddd, J = 2.4, 3.3, and 11. · 4 Hz), 5.25 (2H, dd, J = 2.4 and 8.8 Hz) ppm. I9F NMr (CE) Cl3, 296K, 282 MHz) (5-95.7 (2F, d, JF-F = 12 Hz), -108.03 (2F, d, JF_F = 12 Hz). Example 10 This example illustrates the bicyclic metallized iridium complex- [Ir (acac) {l_ (2,4-difluorophenyl)) in Table 8. Preparation of quinoline} 2] -complex 8-! *. [IrCl {l- (2,4-difluorophenyl) isoxoline} 2] 2 (300 mg '0.212 mmol Ear), sodium acetoacetone (Aldrich chemical Co., 78 g, 0.636 mmol), and 2-ethoxyethanol (1 (ml)) were stirred at 120 ° F for 0.5 hour. The volatile components were then removed in a vacuum. The residue was dissolved in digas methane, and the solution was passed through a pad of silica gel, and digas firing was used as a dissolution solvent. The resulting orange-red filtrate was evaporated to dryness and then suspended in methanol. The precipitated product was separated by filtration and dried in vacuo. Isolated yield = 230 mg (70%). 4 NMR (CD2C12, 296 K '300 MHz) · 5 8 · 40 (2Η, dd, J = 8.8 and 9 Hz), 7.97 (2H, d, J = 8.1 Hz), 7.78 (2H, ddd, J = 0.7, 6.6, and 7.8 Hz), 7.70 (2H, dd, J = 1.3 and 8.4 Hz), 7.66 (2H, d, J = 6.4 Hz), 6.44 (2H, ddd, J = 2.4, 5.9, and, 1〇 · 8 ppm), -51-This paper size is in accordance with Chinese National Standard (CNS) A4 specification (21〇x 297 mm) 1238819 A7 B7 V. Description of the invention (49) 5.68 (2H, dd, J = 2.4 & amp 8.5 Hz), 5.30 (lH, s), 1.78 (6H, s). 19F NMR (CDC13, 296K, 282 MΗζ) 5. " 96 · 15 (2F, d, JF_F = 11.3 Ηζ), -109.13 (2F, d, JF-F = 11.3 Hz). Compounds 8-a to 8-k and 8-s in Table 8 were prepared using similar procedures. Compounds 8-1 to 8-q in Table 8 were prepared using the procedure of Example 2. Example 11 A thin film OLED device was manufactured using the procedure according to Example 7. Table 10 shows the overview and thickness of the device layers. In all cases, the anode system is ITO as discussed above, and the cathode system is A1 having a thickness in the range of 700-760 Angstroms. MPMP = bis [4- (N, N_diethylamine | DPA = 4, 7-di $ 10 I0-2-tolyl] (4-fluorenyl) pyranyl-1,10-morpholine sample HT layer EL layer ET layer (thickness, A) (thickness, person) (thickness, person ) 11-1 MPMP compound 8-a DPA (572) (419) (400) 11-2 MPMP compound 8-b DPA (512) (407) (394) 11-3 MPMP compound 8-c DPA (548) ( 441) (408) -52- This paper size applies to China National Standard (CNS) A4 (210 X 297 mm)

裝 訂Binding

1238819 A7 B7 五、發明説明(5〇 11-4 MPMP 化合物8-d DPA (508) (410) (408) 11-5 MPMP 化合物8-e DPA (560) (421) (407) 11-6 MPMP 化合物8-f DPA (526) (409) (405) 11-7 MPMP 化合物8-g DPA (890) (408) (402) 11-8 MPMP 化合物8-h DPA (514) (465) (403) 11-9 MPMP 化合物8-i DPA (564) (418) (413) 11-10 MPMP 化合物8-j DPA (564) (405) (407) 11-11 MPMP 化合物8-k DPA (522) (400) (408) 11-12 MPMP 化合物8-1 DPA (529) (421) (408) 11-13 MPMP 化合物8-m DPA (530) (411) (411) 11-14 MPMP 化合物8-0 DPA (537) (412) (409) -53- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 12388191238819 A7 B7 V. Description of the invention (50.11-4 MPMP compound 8-d DPA (508) (410) (408) 11-5 MPMP compound 8-e DPA (560) (421) (407) 11-6 MPMP Compound 8-f DPA (526) (409) (405) 11-7 MPMP Compound 8-g DPA (890) (408) (402) 11-8 MPMP Compound 8-h DPA (514) (465) (403) 11-9 MPMP compound 8-i DPA (564) (418) (413) 11-10 MPMP compound 8-j DPA (564) (405) (407) 11-11 MPMP compound 8-k DPA (522) (400 ) (408) 11-12 MPMP compound 8-1 DPA (529) (421) (408) 11-13 MPMP compound 8-m DPA (530) (411) (411) 11-14 MPMP compound 8-0 DPA ( 537) (412) (409) -53- This paper size applies to Chinese National Standard (CNS) A4 (210 X 297 mm) 1238819

A7 B7 五、發明説明(51 ) 11-15 MPMP (509) 化合物8-p (4〇5) DPA (405) 11-16 MPMP (512) 化合物8-q (414) DPA (402) 11-17 MPMP (529) 化合物8-r (442) DPA (412) 11-18 102961-31 MPMP (524) 化合物8-s (407) DPA (408) 如實施例7將OLED樣品定性,及將結果示於下表11。 表11 銥化合物之電發光性質 樣品 尖峰光度 Cd/m2 尖峰效率 Cd/A 大約的尖峰 波長,nm 11-1 45 在22V 0.13 628 11-2 32 在20V 0.12 >600 11-3 340 在24 2.5 590 11-4 350 在22V 1.7 625 -54- 本紙張尺度適用中國國家標準(CNS) A4規格(210 x 297公釐) 1238819 A7 B7 五、發明説明(52 11-5 300 在21V 1.5 >600 11-6 200 在20V 1.1 605, 650 11-7 300 在23V 5 605 11-8 280 在21V 2.9 590 11-9 1000 在20V 3.5 592 1M0 380 在21V 2.3 610, 650 11-11 8 在23V 0.25 624 11-12 800 在20V 2.3 610, 650 11-13 360 在22V 1.5 590 11-14 160 在24V 1.2 590 11-15 80 在21V 1.1 597 -55- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1238819 A7 B7 五、發明説明(53 )A7 B7 V. Description of the invention (51) 11-15 MPMP (509) compound 8-p (405) DPA (405) 11-16 MPMP (512) compound 8-q (414) DPA (402) 11-17 MPMP (529) Compound 8-r (442) DPA (412) 11-18 102961-31 MPMP (524) Compound 8-s (407) DPA (408) The OLED samples were characterized as in Example 7, and the results are shown in Table 11 below. Table 11 Electroluminescence properties of iridium compounds Sample peak photometric Cd / m2 Peak efficiency Cd / A Approximate peak wavelength, nm 11-1 45 at 22V 0.13 628 11-2 32 at 20V 0.12 > 600 11-3 340 at 24 2.5 590 11-4 350 at 22V 1.7 625 -54- This paper size applies Chinese National Standard (CNS) A4 size (210 x 297 mm) 1238819 A7 B7 V. Description of invention (52 11-5 300 at 21V 1.5 > 600 11-6 200 at 20V 1.1 605, 650 11-7 300 at 23V 5 605 11-8 280 at 21V 2.9 590 11-9 1000 at 20V 3.5 592 1M0 380 at 21V 2.3 610, 650 11-11 8 at 23V 0.25 624 11-12 800 at 20V 2.3 610, 650 11-13 360 at 22V 1.5 590 11-14 160 at 24V 1.2 590 11-15 80 at 21V 1.1 597 -55- This paper size applies to China National Standard (CNS) A4 specifications ( 210 X 297 mm) 1238819 A7 B7 V. Description of the invention (53)

11-16 170 在21V 0.8 615 11-17 1300 4 600 在22V 11-18 540 1.6 622 在20V 實施例12 此實施例說明其他之苯基吡啶配位子的製備。 如實施例1中之說明製備下表12所示之苯基吡啶化合物 12-a至 12-j。11-16 170 at 21V 0.8 615 11-17 1300 4 600 at 22V 11-18 540 1.6 622 at 20V Example 12 This example illustrates the preparation of other phenylpyridine ligands. The phenylpyridine compounds 12-a to 12-j shown in Table 12 below were prepared as described in Example 1.

表12 化合物 A Ri r2 Rs R4 Rs FU r7 Rs r9 12-a C H ch3 H H F H F H H 12-b C H ch3 H H H cf3 H cf3 H 12-c c H H ch3 H F H F H H 12-d c H ch3 H H H cf3 H H H 12-e c H H ch3 H H cf3 H cf3 H 12-f c H H H H H cf3 H H H 12-g c H H H H F H F H H 12-h c H t-Bu H H H H F H H 12-i c H t-Bu H H H cf3 H cf3 H 12-i c H ch3 H H H H cf3 H H -56- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1238819 A7 B7 五、發明説明(54 分析及NMR數據示於下表13。表13 化合物 產率 (%) B.p./ ιηπι Hg (m.p.) °C NB No 1hnmr 19FNMR 12-a 61.5 70-72/0.03 101394-104 2.39(3H), 6‘99(2H)、 7.02(1 H), 7.57(1 H), 7.99(1 H) 8JS6(1H) -102.96 (IF, m), -113,18 〇F,m) 12-b 39 66-68/0.01 101394-115^ 2.47(3 H), 7.I7(1H), 7.63(1¾ 7.91(1¾ S.4«(2H), 8.60(111), 9.D0(1H) -63.23 (s) 1Z-C 76 75-76/0.01 (54-56) 101394-12J 2.25(3»), 6.90(2H), 7.55(2H), S.50(1H), 8.35(1 H), 10.37 (IF, m) -113.50 (lF.m) 12-d 76 69^70/0.06 (44-46) 101394-129 2.35(3H), 7.05(1H), 7-55(210, S.010H), 8.18(1H), 8.50(IH) -63.03 (s) -57- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1238819 A7 B7 五、發明説明(55 化合物 產率 (%) Β.ρ7 mm Hg (m.p.) °C ND No ^NMR J9F nmr 12-« 84 (83-85) 102960-48 2.43(3H) 7.66(1 H)7 7.87(1¾ S*47(2H), S.59(1H) -63.IS (s) I2-f 72 64-65/0.026 99344-Π 7.20(1 H), 7.65(3H)S 8.10(1 HX S.n(lH), S.65(1H), 9.43(1 H) -63.05 (s) 12-g 3d 62/0.01 101394-93 6.90(1 H), 7.1S(2HX 7.6S(2H), 7.95(1 H), S.65(IH), -109.70 〇F,m) -113.35 (IF, m) 12-h 49 99-101/0.26 102960-Π7 - - .12-i 58 108-109/CJ 103555-3 1.35(9 H) 7.34(1 H) 7.72(1 H) 7.$S(1H) 8.44(2H) 8.6K1H) -63.29 12-j 46 76-77/01 (52-54) 1 102960-143 2.46(3H) 7.15(1H) 7.60() H) 7.73(2H) 8.11(2H) 8-59(iH) -62.86 -58- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1238819 A7 B7 五、發明説明(56 在[(dppb)PdCl2]催化劑(dppb = 1,4-雙(二苯膦基)丁烷) 之存在下,經由2 -氣-5-三氟曱基吡啶與溴化2,4-二甲氧笨 基鎂之庫馬達(Kumada)偶合作用製備得2-(2,,4,-二甲氧苯 基)-5 -二氟甲基°比唆。 實施例13 此實施例說明二氣橋連雙核雙環金屬化ΙΓ錯合物之形成。Table 12 Compound A Ri r2 Rs R4 Rs FU r7 Rs r9 12-a CH ch3 HHFHFHH 12-b CH ch3 HHH cf3 H cf3 H 12-cc HH ch3 HFHFHH 12-dc H ch3 HHH cf3 HHH 12-ec HH ch3 HH cf3 H cf3 H 12-fc HHHHH cf3 HHH 12-gc HHHHFHFHH 12-hc H t-Bu HHHHFHH 12-ic H t-Bu HHH cf3 H cf3 H 12-ic H ch3 HHHH cf3 HH -56- This paper is applicable to China Standard (CNS) A4 specification (210 X 297 mm) 1238819 A7 B7 V. Description of the invention (54 Analysis and NMR data are shown in Table 13 below. Table 13 Compound yield (%) Bp / ιηπι Hg (mp) ° C NB No 1hnmr 19FNMR 12-a 61.5 70-72 / 0.03 101394-104 2.39 (3H), 6'99 (2H), 7.02 (1 H), 7.57 (1 H), 7.99 (1 H) 8JS6 (1H) -102.96 (IF, m), -113,18 〇F, m) 12-b 39 66-68 / 0.01 101394-115 ^ 2.47 (3 H), 7.I7 (1H), 7.63 (1¾ 7.91 (1¾ S.4 `` (2H), 8.60 (111), 9.D0 (1H) -63.23 (s) 1Z-C 76 75-76 / 0.01 (54-56) 101394-12J 2.25 (3 »), 6.90 (2H), 7.55 (2H), S.50 (1H), 8.35 (1 H), 10.37 (IF, m) -113.50 (lF.m) 12-d 76 69 ^ 70 / 0.06 (44-46) 101394-129 2.35 (3H ), 7.05 (1H), 7-55 (210, S.010H), 8.18 (1H), 8.50 (IH) -63.03 (s) -57- This paper size applies to China National Standard (CNS) A4 (210 X 297 mm) 1238819 A7 B7 V. Description of the invention (55 Compound yield (%) Β.ρ7 mm Hg (mp) ° C ND No ^ NMR J9F nmr 12- «84 (83-85) 102960-48 2.43 (3H) 7.66 (1 H) 7 7.87 (1¾ S * 47 (2H), S.59 (1H) -63.IS (s) I2-f 72 64-65 / 0.026 99344-Π 7.20 (1 H), 7.65 (3H) S 8.10 (1 HX Sn (lH), S .65 (1H), 9.43 (1 H) -63.05 (s) 12-g 3d 62 / 0.01 101394-93 6.90 (1 H), 7.1S (2HX 7.6S (2H), 7.95 (1 H), S. 65 (IH), -109.70 〇F, m) -113.35 (IF, m) 12-h 49 99-101 / 0.26 102960-Π7--.12-i 58 108-109 / CJ 103555-3 1.35 (9 H ) 7.34 (1 H) 7.72 (1 H) 7. $ S (1H) 8.44 (2H) 8.6K1H) -63.29 12-j 46 76-77 / 01 (52-54) 1 102960-143 2.46 (3H) 7.15 (1H) 7.60 () H) 7.73 (2H) 8.11 (2H) 8-59 (iH) -62.86 -58- This paper size applies to China National Standard (CNS) A4 (210 X 297 mm) 1238819 A7 B7 5 2. Description of the invention (56 in the presence of [(dppb) PdCl2] catalyst (dppb = 1,4-bis (diphenylphosphino) butane)), via 2-gas-5-trifluorofluorinylpyridine and bromide 2 , 4-two Kuma Da magnesium oxide stupid group (the Kumada) the conjugation was prepared to give 2- (2,, 4, - dimethoxybenzene-yl) -5 - difluoromethyl ° instigate ratio. Example 13 This example illustrates the formation of a bigas bridged dinuclear bicyclic metallization IΓ complex.

Ir錯合物係由在IrCl3.nH2〇與相對之2·芳基吡啶於2-乙氧 乙醇水溶液中之反應而製備得。此方法係與苯基吡啶之 文獻步驟類似(Sprouse,S.; King,K.A.; Spellane,P. Watts,R· J·,J. Am· Chem· Soc.,1984,106,6647-53; Garces,F· 0·; King,K. A.; Wans,R. J·,Inorg. Chem., 1988,2 7,3464-71)。使 irCl3nH2〇、2-芳基吡啶(每 Ir 2.2-2.8當量)、2-乙氧乙醇(每1克之IrCl3.nH2〇約30毫 升)、及水(每30毫升之2_乙氧乙醇約5毫升)之混合物在迴 流下(N2)劇烈授拌4-1 0小時。於冷卻至室溫後,加入濃 HC1(每1克之IrCh.ni^O 3毫升),及使混合物攪拌30分 鐘。將混合物以水稀釋,攪拌1-2小時,及過濾。將固體產 物以水、甲醇洗滌,並於真空中乾燥。產率係自6 5至 99% 〇 實施例14 此實施例說明具有第六化學式(其中L”為cl)之本發明之Ir. 錯合物的形成。 含有單牙图―膦、co、一或異腈配位子之二環金屬化芳基 吡啶銥ΠΙΙ)箪核錯合物 -59- 本紙張尺度適用中國國家標準(CNS) Α4規格(210 X 297公釐) A7 B7 1238819 五、發明説明(57 ) 使如實施例13所製得之二氣橋連雙核雙環金屬化lr錯合 物、單牙團配位子L’、及1,2-二氣乙烷(DCE)或甲苯之混合 物在迴流下(N2或C0(當L,為C0時))攪拌,直至所有固體皆 溶解為止,然後再多攪拌3分鐘小時。經由蒸發及於空氣 中結晶而將產物分離及純化。將選定錯合物的詳細步驟說 明於下。利用NMR光譜數據(31p NMR = hp-yHJNMR) 將所有的錯合物定性。由於錯合物之不足夠的熱安定性, 因而並未得到令人滿意的燃燒分析。利用單晶1射線繞射 將化合物9-k之兩異構物—具有氮反式之主要異構物及具有 氮順式之次要異構物-定性。 錯合物9-d(裊9、 使利用實施例12之苯基吡啶化合物12-f製得之二氯橋連 雙核雙環金屬化Ir錯合物(1〇〇毫克)、作為配位子l,之配位 子 NC-1(其係 2,6-(CH3)2C6H3NC)(26 毫克)(購自 Fluka line of chemicals,Sigma-Aldrich)、及DCE(1.5 毫升)之 混合物在迴流下攪拌5分鐘。當冷卻至室溫時,以己烷(丄5 毫升,逐份)處理帶強烈青綠色的光致發光溶液。將黃色晶 體分離’以己烧(3x3毫升)洗滌,及於真空中乾燥。產率:The Ir complex is prepared by reacting IrCl3.nH2O with the corresponding 2-arylpyridine in an aqueous solution of 2-ethoxyethanol. This method is similar to the literature procedure of phenylpyridine (Sprouse, S .; King, KA; Spellane, P. Watts, R.J., J. Am. Chem. Soc., 1984, 106, 6647-53; Garces King, KA; Wans, R. J., Inorg. Chem., 1988, 27, 3464-71). Make irCl3nH20, 2-arylpyridine (2.2-2.8 equivalents per Ir), 2-ethoxyethanol (approximately 30 ml per 1 g of IrCl3.nH20), and water (approximately 5 per 30 ml of 2-ethoxyethanol) The mixture was stirred vigorously under reflux (N2) for 4 to 10 hours. After cooling to room temperature, concentrated HC1 (3 ml of IrCh.ni ^ O per 1 g) was added, and the mixture was stirred for 30 minutes. The mixture was diluted with water, stirred for 1-2 hours, and filtered. The solid product was washed with water, methanol and dried in vacuo. Yields are from 65 to 99%. Example 14 This example illustrates the formation of an Ir. Complex of the invention having a sixth chemical formula (where L "is cl). Contains a monodentate graph-phosphine, co, a Or isonitrile ligand bicyclic metallized arylpyridine iridium ΠΙΙ) plutonium complex-59- This paper size applies to Chinese National Standard (CNS) A4 specification (210 X 297 mm) A7 B7 1238819 V. Invention Explanation (57) The two gas-bridged dinuclear bicyclic metallized lr complexes, monodentate ligand L ', and 1,2-digas ethane (DCE) or toluene were prepared as in Example 13. The mixture was stirred under reflux (N2 or C0 (when L is C0)) until all solids were dissolved, and then stirred for an additional 3 minutes. The product was isolated and purified by evaporation and crystallization in air. Selected The detailed steps of the complex are described below. All the complexes were characterized using NMR spectral data (31p NMR = hp-yHJNMR). Due to the insufficient thermal stability of the complexes, no satisfactory results were obtained. Combustion analysis. Using single crystal 1-ray diffraction to separate two isomers of compound 9-k- Major isomers and minor isomers with nitrogen cis-qualitative. Complex 9-d (袅 9. Dichloro-bridged dinuclear bicyclic ring prepared using the phenylpyridine compound 12-f of Example 12 Metallized Ir complex (100 mg), as ligand 1, the ligand NC-1 (which is 2,6- (CH3) 2C6H3NC) (26 mg) (purchased from Fluka line of chemicals, The mixture of Sigma-Aldrich) and DCE (1.5 ml) was stirred under reflux for 5 minutes. When cooled to room temperature, the photoluminescence solution with a strong turquoise color was treated with hexane (丄 5 ml in portions). Yellow crystals were isolated ', washed with hexane (3x3 ml), and dried in vacuo. Yield:

0.115 克(96%)。4 NMR (CD2C12,20。〇,5 : 2.2 (s, 6H,CH3),6.35 (d,1H,芳環H),6.65 (d,1H,芳環H), 7.1 (m,4H,芳環H),7.3 (m,1H,芳環H),7.5 (m,1H, 芳環H),7.9 (d,2H,芳環H),8.1 (m,5H,芳環H),9·4 (d, 1H,芳環 H), 1〇·〇 (d, 1H,芳環 H) 。19F NMR (CD2C12,20°C),δ ·· -62·7 (s,3F,CF3),-62.8 (s,3F, -60- 本紙張尺度適用中國國家標準(CNS) A4規格(210 x 297公釐)0.115 g (96%). 4 NMR (CD2C12, 20.0, 5: 2.2 (s, 6H, CH3), 6.35 (d, 1H, aromatic ring H), 6.65 (d, 1H, aromatic ring H), 7.1 (m, 4H, aromatic ring H), 7.3 (m, 1H, aromatic ring H), 7.5 (m, 1H, aromatic ring H), 7.9 (d, 2H, aromatic ring H), 8.1 (m, 5H, aromatic ring H), 9.4 (d, 1H, aromatic ring H), 10.0 (d, 1H, aromatic ring H). 19F NMR (CD2C12, 20 ° C), δ · -62 · 7 (s, 3F, CF3),- 62.8 (s, 3F, -60- This paper size applies to China National Standard (CNS) A4 (210 x 297 mm)

裝 訂Binding

1238819 A7 B7 五、發明説明(58 ) cf3)。 錯合物9-g(表9V : 使利用實施例1之苯基吡啶化合物2-y製得之二氣橋連雙 核雙環金屬化Ir錯合物(120毫克)、作為配位子L,之配位子 NC-1(其係 2,6-(CH3)2C6H3NC)(26 毫克)(購自 Fluka line of chemicals,Sigma-Aldrich)、及 DCE(2 毫升)之混合物 在迴流下攪拌10分鐘。當冷卻至室溫時,以己烷(4毫升, 逐份)處理帶強烈青綠色的光致發光溶液。將黃色晶體分 離’以己烧(3x3毫升)洗務,及於真空中乾燥。產率:0.13 克(93%)。4 NMR (CD2C12,20。〇,(5 : 2.2 (s,6H, CH3),6.35 (d,1H,芳環H),6.65 (d,1H,芳環Η),7·1 (m,5Η,芳環Η),8.0 (d,2Η,芳環Η),8.25 (m,4Η,芳環 H),9.6 (s,1H,芳環H),10.4 (s,1H,芳環H)。19F NMR (CD2C12,2〇t),5 ·· -62.8 (s,6F,CF3),-62.9 (s,3F, CF3),-63.0 (s,3F,CF3)。 錯合物9-K轰9、 使利用實施例1之苯基吡啶化合物2-k製得之二氣橋連雙 核雙環金屬化Ir錯合物(300毫克)、作為配位子L,之三苯膦 (120毫克)、及甲苯(6毫升)之混合物在迴流下攪拌1〇分 鐘。當冷卻至室溫時,自綠色光致發光溶液沉澱出黃色晶 體。於在室溫下2天後,加入己烷(8毫升)。於1天後,將黃 色晶體分離,以己烧(3 X 3毫升)洗條,及於真空中乾燥。 產率:0.41 克(97%)。4 NMR (CD2C12,20。〇,5 : 5.5 (m,2H,芳環H),6.7 (m,2H,芳環H),7.2-7.9 (m, -61 -1238819 A7 B7 V. Description of the invention (58) cf3). 9-g complex (Table 9V: the digas-bridged binuclear bicyclic metallized Ir complex (120 mg) prepared using the phenylpyridine compound 2-y of Example 1 as the ligand L, A mixture of the ligand NC-1 (which is 2,6- (CH3) 2C6H3NC) (26 mg) (purchased from Fluka line of chemicals, Sigma-Aldrich), and DCE (2 ml) was stirred under reflux for 10 minutes. When cooled to room temperature, the photoluminescence solution with a strong turquoise color was treated with hexane (4 ml in portions). The yellow crystals were separated and washed with hexane (3 x 3 ml) and dried in vacuum. Rate: 0.13 g (93%). 4 NMR (CD2C12, 20.0, (5: 2.2 (s, 6H, CH3), 6.35 (d, 1H, aromatic ring H), 6.65 (d, 1H, aromatic ring) ), 7.1 (m, 5Η, aromatic ring Η), 8.0 (d, 2Η, aromatic ring Η), 8.25 (m, 4Η, aromatic ring H), 9.6 (s, 1H, aromatic ring H), 10.4 ( s, 1H, aromatic ring H). 19F NMR (CD2C12, 20t), 5 ·· -62.8 (s, 6F, CF3), -62.9 (s, 3F, CF3), -63.0 (s, 3F, CF3 ). Complex 9-K-Bom 9, the bi-gas-bridged binuclear bicyclic metallization Ir obtained using the 2-phenylpyridine compound 2-k of Example 1 A mixture of the compound (300 mg), triphenylphosphine (120 mg), and toluene (6 ml) as the ligand L was stirred under reflux for 10 minutes. When cooled to room temperature, the photoluminescence from green The solution precipitated yellow crystals. After 2 days at room temperature, hexane (8 mL) was added. After 1 day, the yellow crystals were separated, the strip was washed with hexane (3 X 3 mL), and dried in vacuum Yield: 0.41 g (97%). 4 NMR (CD2C12, 20.0, 5: 5.5 (m, 2H, aromatic ring H), 6.7 (m, 2H, aromatic ring H), 7.2-7.9 (m, -61-

本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1238819 A7 B7 五、發明説明(59 ) 21H,芳環H),8.05 (s,2H,芳環H),9.15 (s,1H,芳環H), 9.65 (s,1H,芳環H)。19f NMR (CD2C12,20。〇,5 : -62.9 (s,3F,CF3),_63·0 (s,3F,CF3),-107.9 (m,1F, 芳環F),-108.3 (m,1F,芳環F)。31P NMR (CD2C12,20 °C),5…3·2 (d,JP_F = 5 9 Hz)。產物包含具有以下之 NMR參數的次要異構物(約ι〇%) : 19f NMR (CD2CI2, 20。〇,6 : _63·5 (s,3F,Cf3),_63 9 (s,3F,cf3), -107.4 (m,1F,芳環 f),_l〇8.9 (m,1F,芳環 F)。31P NMR (CD2C12,20。〇,6 ·· _ΐ〇·8 (d,JP_F = 6.3 Hz)。 錯合物9-k(表9) 使利用實施例1之苯基α比咬化合物2-k製得之二氯橋連雙 核雙環金屬化Ir錯合物(1〇2毫克)、作為配位子L,之三芳基 膦化合物(Arf)3P(其中 Arf = 3,5-(CF3)2C6H3)(102 毫克)、 及甲苯(8毫升)之混合物在迴流下攪拌1〇分鐘,直至所有固 體皆溶解為止。於冷卻至室溫後,以己烷(1()毫升)處理混 合物’並於約+10 °C下維持3小時。將黃色結晶固體分離, 以己烷洗滌’及於真空中乾燥。化合物展現天空藍的光致 發光。此產物之19F NMR分析指示約1〇%之未反應的二氣 橋連錯合物。於將固體在1^(30毫克)之存在下在沸騰甲苯 中加熱,然後再在約+ 1〇。(:下冷卻12小時後,分離出沒有任 何二氯橋連錯合物之錯合物9-k。將其以己烷洗滌,並於真 空中乾燥。產率:0.17 克(86%)。4 NMR (CD2C12,20 C),5 : 5.4 (m,1H,芳環H),5.9 (m,1H,芳環H),0.75 (m,2H,芳環H),7.2 (m,2H,芳環H),7.75 (m,2H,芳環 -62- 冢紙張尺度適用中國國家標準(CNS) A4規格(21〇x 297公釐) ' 1238819 A7 -----Ί 五、發明説明(60 ) H),7.9 (m,7H,芳環H),8.05 (s,2H,芳環H),8.15 〇, 2H,芳環H),8.85 (s,1H,芳環H),9.4 (s,1H,芳環H)。 19F NMR (CD2C12,20°C),6 : -63.2 (s,3F,CF3), -63.9 (s,3F,CF3),·64.0 (s,18F,L5 CF3), -105.4 〇, iF,芳環 F),-106.1 (m, if,芳環 F)。31P NMR (CD2C12 ’ 20°C),δ : _2·2 (d,JP-F = 5.9 Hz)。此錯合物 具有彼此為反式的氮原子射線)。在進行x_射線分析之 單晶中’亦發現一些不同形狀的晶體。亦利用x-射線繞射 對其之一者進行分析,其確定次要異構物之在Ir周圍之Ν原 子的順位配置。 錯合物 使作為L’之一氧化碳發泡通過由實施例1之苯基吡啶化合 物2-k製得之二氣橋連雙核雙環金屬化Ir錯合物(18〇毫克)於 DCE(8毫升)中之沸騰溶液。將加熱器關閉,及使溶液在 CO發泡通過混合物之下緩慢冷卻至室溫。當淡黃色的晶體 開始沉澱時,以2毫升的份量緩慢地加入己烷(10毫升)。於 在室溫下30分鐘後,將晶體(偏白藍色的光致發光)分離, 以己烷洗滌,並於真空中乾燥I5分鐘。產率:0.145克 (78%)。4 NMR (CD2C12,20。〇,5 : 5.6 (m,1H,芳 環H),6.15 (m,1H,芳環H),6.8 (m,2H,芳環H),7.8 (m, 2H,芳環H),8.1 (m,2H,芳環H),8.25 (m,2H,芳環H), 9.2 (s,1H,芳環H),10.15 (s,1H,芳環H)。19F NMH (CD2C12,20〇C),5 : _62·8 (s,3F,CF3),·62·9 (s,3F, CF3),_106.5 (m,1F,芳環F),-106.7 (m,1F,芳環F)。 -63- 本紙張尺度適用中國國家標準(CNS) A4規格(210X 297公董) 1238819 A7 B7 ____ 五、發明説明(61 ) 使用與錯合物9-d相同之步驟,分別使用苯基吡啶化合物 12-a、12-c、12-g、12-d、2-k、12-f、及2-k,製得錯合 物9-a、9-b、9-c、9-e、9-f、9-h、及9-i。 實施例15 使用根據實施例7之步驟製造薄膜OLED裝置。表14顯示 裝置層的概述及厚度。在所有情況中,陽極係如以上所論 述的ITO,及陰極係具有在700-760埃之範圍内之厚度的 A1 〇 表 MPMP =雙[4-(N,N-二乙胺;1 DPA = 4,7d 14 10-2-甲苯基](4-甲苯基)甲烷 良基-1,10-啡啉 樣品 HT層 EL層 ET層 (厚度,A) (厚度,A) (厚度,A) 15-1 MPMP 化合物9-a DPA (516) (408) (413) 15-2 MPMP 化合物9-c DPA (518) (404) (402) 15-3 MPMP 化合物9-d DPA (508) (354) (421) 15-4 MPMP 化合物9-e DPA (504) (403) (410) 15-5 MPMP 化合物9-f DPA 102924-5 (501) (407) (415) -64- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1238819 A7 B7 五、發明説明(62 如實施例7將OLED樣品定性,及將結果示於下表15。 表15 銥化合物之電發光性質 樣品 尖峰光度 尖峰效率 大約的 Cd/m2 Cd/A 尖峰波長,nm 15-1 6 在16V 0.7 450 + 500 15-2 1 在21V 0.25 510 15-3 60 在22V 0.8 464 + 493 15-4 25 在23V 1.2 460 + 512 15-5 320 在22V 2.4 538 15-6 350 在23V 1.5 484 + 509This paper size applies to Chinese National Standard (CNS) A4 (210 X 297 mm) 1238819 A7 B7 V. Description of the invention (59) 21H, aromatic ring H), 8.05 (s, 2H, aromatic ring H), 9.15 (s , 1H, aromatic ring H), 9.65 (s, 1H, aromatic ring H). 19f NMR (CD2C12, 20.0, 5: -62.9 (s, 3F, CF3), -63 · 0 (s, 3F, CF3), -107.9 (m, 1F, aromatic ring F), -108.3 (m, 1F , Aromatic ring F). 31P NMR (CD2C12, 20 ° C), 5 ... 3.2 (d, JP_F = 59 Hz). The product contains minor isomers with the following NMR parameters (about 10%) : 19f NMR (CD2CI2, 20.0, 6: _63 · 5 (s, 3F, Cf3), _63 9 (s, 3F, cf3), -107.4 (m, 1F, aromatic ring f), _108.9 (m , 1F, aromatic ring F). 31P NMR (CD2C12, 20.0, 6 ·· _ΐ〇 · 8 (d, JP_F = 6.3 Hz). Complex 9-k (Table 9) The benzene of Example 1 was used Dichloro-bridged dinuclear bicyclic metallized Ir complex (102 mg) prepared as a ligand α to bite compound 2-k, and as a ligand L, a triarylphosphine compound (Arf) 3P (where Arf = 3 The mixture of 5- (CF3) 2C6H3) (102 mg) and toluene (8 ml) was stirred at reflux for 10 minutes until all solids were dissolved. After cooling to room temperature, hexane (1 () Ml) The mixture was treated 'and maintained at about +10 ° C for 3 hours. The yellow crystalline solid was separated, washed with hexane' and dried in vacuo. The product exhibited sky blue photoluminescence. 19F NMR analysis of this product indicated about 10% unreacted digas bridged complex. The solid was heated in boiling toluene in the presence of 1 ^ (30 mg) , And then again at about +10. (: After cooling for 12 hours, the complex 9-k without any dichlorobridged complex was isolated. It was washed with hexane and dried in vacuum. Product Rate: 0.17 g (86%). 4 NMR (CD2C12, 20 C), 5: 5.4 (m, 1H, aromatic ring H), 5.9 (m, 1H, aromatic ring H), 0.75 (m, 2H, aromatic ring) H), 7.2 (m, 2H, aromatic ring H), 7.75 (m, 2H, aromatic ring -62-) The paper size is applicable to the Chinese National Standard (CNS) A4 specification (21〇x 297 mm) '1238819 A7- --- Ί V. Description of the invention (60) H), 7.9 (m, 7H, aromatic ring H), 8.05 (s, 2H, aromatic ring H), 8.15, 2H, aromatic ring H), 8.85 (s, 1H, aromatic ring H), 9.4 (s, 1H, aromatic ring H). 19F NMR (CD2C12, 20 ° C), 6: -63.2 (s, 3F, CF3), -63.9 (s, 3F, CF3), 64.0 (s, 18F, L5 CF3), -105.4 0, iF, aromatic ring F), -106.1 (m, if, aromatic ring F). 31P NMR (CD2C12 ′ 20 ° C), δ: _2 · 2 (d, JP-F = 5.9 Hz). This complex has nitrogen atom rays that are trans to each other). Some crystals of different shapes were also found in single crystals subjected to x-ray analysis. X-ray diffraction is also used to analyze one of them, which determines the ordinal arrangement of the N atoms of the minor isomers around Ir. The complex blew carbon oxide as one of L ′ through a bi-gas-bridged dinuclear bicyclic metallized Ir complex (18 mg) in DCE (8 ml) prepared from phenylpyridine compound 2-k of Example 1. In boiling solution. The heater was turned off and the solution was allowed to slowly cool to room temperature under CO foaming through the mixture. When the pale yellow crystals started to precipitate, hexane (10 ml) was slowly added in 2 ml portions. After 30 minutes at room temperature, the crystals (whiteish blue photoluminescence) were separated, washed with hexane, and dried under vacuum for 15 minutes. Yield: 0.145 g (78%). 4 NMR (CD2C12, 20.0, 5: 5.6 (m, 1H, aromatic ring H), 6.15 (m, 1H, aromatic ring H), 6.8 (m, 2H, aromatic ring H), 7.8 (m, 2H, Aromatic ring H), 8.1 (m, 2H, aromatic ring H), 8.25 (m, 2H, aromatic ring H), 9.2 (s, 1H, aromatic ring H), 10.15 (s, 1H, aromatic ring H). 19F NMH (CD2C12, 20 ° C), 5: _62 · 8 (s, 3F, CF3), · 62 · 9 (s, 3F, CF3), _106.5 (m, 1F, aromatic ring F), -106.7 ( m, 1F, aromatic ring F). -63- This paper size applies to China National Standard (CNS) A4 (210X 297 public directors) 1238819 A7 B7 ____ 5. Description of the invention (61) Use the same as the complex 9-d In the step, phenylpyridine compounds 12-a, 12-c, 12-g, 12-d, 2-k, 12-f, and 2-k are used to prepare complexes 9-a and 9-b, respectively. , 9-c, 9-e, 9-f, 9-h, and 9-i. Example 15 A thin-film OLED device was manufactured using the procedure according to Example 7. Table 14 shows the overview and thickness of the device layers. In all cases The anode system is ITO as discussed above, and the cathode system is A1 with a thickness in the range of 700-760 Angstroms. MPMP = bis [4- (N, N-diethylamine; 1 DPA = 4,7d 14 10-2-Tolyl) (4-Tolyl) methane -1,10-morpholine sample HT layer EL layer ET layer (thickness, A) (thickness, A) (thickness, A) 15-1 MPMP compound 9-a DPA (516) (408) (413) 15- 2 MPMP compound 9-c DPA (518) (404) (402) 15-3 MPMP compound 9-d DPA (508) (354) (421) 15-4 MPMP compound 9-e DPA (504) (403) ( 410) 15-5 MPMP compound 9-f DPA 102924-5 (501) (407) (415) -64- This paper size applies to Chinese National Standard (CNS) A4 (210 X 297 mm) 1238819 A7 B7 V. DESCRIPTION OF THE INVENTION (62) The OLED samples were characterized as in Example 7, and the results are shown in Table 15 below. Table 15 Electroluminescence properties of iridium compounds Sample peak photometric peak efficiency Approximate Cd / m2 Cd / A peak wavelength, nm 15-1 6 at 16V 0.7 450 + 500 15-2 1 at 21V 0.25 510 15-3 60 at 22V 0.8 464 + 493 15-4 25 at 23V 1.2 460 + 512 15-5 320 at 22V 2.4 538 15-6 350 at 23V 1.5 484 + 509

裝 訂Binding

15-6 MPMP 化合物9-g DPA 102924-40 (518) (404) (405) -65- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐)15-6 MPMP compound 9-g DPA 102924-40 (518) (404) (405) -65- This paper size applies Chinese National Standard (CNS) A4 specification (210 X 297 mm)

Claims (1)

123 881贫090133244號專利申請案 _中文申請專利範圍替換本(93年6月g 六、申請專利範圍 1. 一種化合物,其係選自下所列化合物8-a至8-5 ·· 化合物 化學式 La,Lb,Lc y ζ R取代基 L, L,, 8-3. IrLaLbL,yL,,z 結構(I) 1 0 r3 = cf3 R7 = F (a) Me-8hq 8-b IrLaLbL’yL,,z 結構(I) 1 0 R3 = CF3 R7 = F (a) 8hq 8-c IrLaLbL,yLnz 結構(XI) 1 0 Rl8 = CF3 (a) acac - 8-d IrLaLbL,yL’’z 結構(ΧΠ) 1 0 R29 = CF3 (a) acac - 8-e IrLaLbL’yL"z 結構(χπ) 1 0 R28 = CF3 (a) acac - 8-f IrLaLbL,yL”z 結構(ΧΠ) 1 0 R29 = F (a) acac - 8-g IrLaLbL,yL,’z 結構(χπ) 1 0 R27 = F R29 = F (a) acac 8-h IrLaLbL’yL”z 結構(χπ) 1 0 R27 = F R29 = F R30 = F (a) acac 8-i IrLaLbL’yL’,z 結構(χπ) 1 0 R28 = F R-29 = F R30 = F (a) acac 8-j IrLaLbL,yL”z 結構(χπ) 1 0 R28 = F R30 = F (a) acac 8-k IrLaLbL,yL,,z 結構(χπ) 1 0 R29 = CgFi7 (a) acac - 8-1 IrLaLbLc 結構(χπ) - - R29 = CF3 (a) - - 本紙張尺度適用中國國家標準(CNS) A4規格(210X 297公釐) 1238819 έβ8 C8 D8 六、申請專利範圍 8-m IrLaLbLc 結構(ΧΠ) R28 =F R29 = F R30 = F (a) 8-n IrLaLbLc 結構(ΧΠ) R27 = F R29 = F R30 = F (a) 8-0 IrLaLbLc 結構(ΧΠ) R27 = F R29 = F (a) 8-p IrLaLbLc 結構(ΧΠ) - - R28 = CF3 (a) - - 8-q IrLaLbLc 結構(ΧΠ) R28 = F R3〇 = F (a) 8-r IrLaLbL,yL,,z 結構(ΧΠ) 1 0 R27 = F R29 = F ⑻ acac 8-s IrLaLbL’yL,,z 結構(ΧΠ) 1 0 R29 = OCF3 (a) acac - 其中: 結構(I)代表123 881ane 090133244 Patent Application_Chinese Patent Application Replacement (June 1993g VI. Application Patent Scope 1. A compound selected from the compounds 8-a to 8-5 listed below ... La, Lb, Lc y ζ R substituents L, L ,, 8-3. IrLaLbL, yL ,, z Structure (I) 1 0 r3 = cf3 R7 = F (a) Me-8hq 8-b IrLaLbL'yL, , Z structure (I) 1 0 R3 = CF3 R7 = F (a) 8hq 8-c IrLaLbL, yLnz structure (XI) 1 0 Rl8 = CF3 (a) acac-8-d IrLaLbL, yL''z structure (XΠ ) 1 0 R29 = CF3 (a) acac-8-e IrLaLbL'yL " z structure (χπ) 1 0 R28 = CF3 (a) acac-8-f IrLaLbL, yL "z structure (χΠ) 1 0 R29 = F (a) acac-8-g IrLaLbL, yL, 'z structure (χπ) 1 0 R27 = F R29 = F (a) acac 8-h IrLaLbL'yL ”z structure (χπ) 1 0 R27 = F R29 = F R30 = F (a) acac 8-i IrLaLbL'yL ', z structure (χπ) 1 0 R28 = F R-29 = F R30 = F (a) acac 8-j IrLaLbL, yL "z structure (χπ) 1 0 R28 = F R30 = F (a) acac 8-k IrLaLbL, yL ,, z structure (χπ) 1 0 R29 = CgFi7 (a) acac-8-1 IrLaLbLc structure (χπ)--R29 = CF3 (a)--This paper size applies the Chinese National Standard (CNS) A4 specification (210X 297 mm) 1238819 έ β8 C8 D8 VI. Application scope of patent 8-m IrLaLbLc Structure (XΠ) R28 = F R29 = F R30 = F ( a) 8-n IrLaLbLc structure (XΠ) R27 = F R29 = F R30 = F (a) 8-0 IrLaLbLc structure (XΠ) R27 = F R29 = F (a) 8-p IrLaLbLc structure (XΠ)--R28 = CF3 (a)--8-q IrLaLbLc structure (XΠ) R28 = F R3〇 = F (a) 8-r IrLaLbL, yL ,, z structure (XΠ) 1 0 R27 = F R29 = F ⑻ acac 8- s IrLaLbL'yL ,, z structure (χΠ) 1 0 R29 = OCF3 (a) acac-where: Structure (I) represents 其中,A係C : 結構(XI)代表 -2 - 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1238819 A8 B8 C8 D8 六、申請專利範圍Among them, A series C: Structure (XI) representative -2-This paper size is applicable to Chinese National Standard (CNS) A4 specification (210 X 297 mm) 1238819 A8 B8 C8 D8 6. Scope of patent application (X0(X0 (a)代表其餘R取代基為氫; 8hq代表8-經基峻琳根; Me-8hq代表2-甲基-8-羥基喹啉根;及 acac代表2,4-戊二酮根。 2. —種有機電子裝置,包括在兩電接觸層之間之至少一活 性層,其中該至少一活性層包括選自根據申請專利範圍 第1項之化合物。 3. 根據申請專利範圍第2項之裝置,其中該活性層係為光發 射層。 4. 根據申請專利範圍第2項之裝置,其中該活性層係為電荷 輸送層。 5. 一種有機電子裝置,包括具有在570至700毫微米之範圍 内之發射最大值的發射層,其中發射層之至少20重量百 分比包括具有以下之第二化學式的至少一化合物: IrLaLbL’yL”z (第二化學式) -3- 本紙張尺度適用中國國家標準(CNS) A4規格(210X297公釐) A8 B8 C8 D8 1238819 六、申請專利範圍 其中: y為1 ; z為0 ; L’為雙牙團配位子,且不為苯基吡啶、苯基嘧啶、 或苯基p奎琳; L"為單牙團配位子,且不為苯基吡啶、笨基嘧啶、 或苯基p奎琳; La&Lb係彼此相似或不同,且各La&Lb具有選自以 下之結構(XI)及結構(ΧΠ)的結構:(a) represents the remaining R substituents are hydrogen; 8hq represents 8-Cycloline; Me-8hq represents 2-methyl-8-hydroxyquinoline; and acac represents 2,4-pentanedione. 2. An organic electronic device comprising at least one active layer between two electrical contact layers, wherein the at least one active layer includes a compound selected from the group consisting of the first item of the patent application. 3. The device according to item 2 of the scope of patent application, wherein the active layer is a light emitting layer. 4. The device according to item 2 of the scope of patent application, wherein the active layer is a charge transport layer. 5. An organic electronic device comprising an emission layer having an emission maximum in a range of 570 to 700 nm, wherein at least 20% by weight of the emission layer includes at least one compound having the following second chemical formula: IrLaLbL'yL " z (Second Chemical Formula) -3- This paper size is applicable to Chinese National Standard (CNS) A4 specification (210X297 mm) A8 B8 C8 D8 1238819 6. Scope of patent application Among them: y is 1; z is 0; L 'is double Pellet ligand, and not phenylpyridine, phenylpyrimidine, or phenyl p-quinine; L " is a single-group ligand, and not phenylpyridine, phenylpyrimidine, or phenyl p-quinine La & Lb is similar or different from each other, and each La & Lb has a structure selected from the following structure (XI) and structure (XΠ): R10至R19之至少一者係選自F、、 〇CnF2n+1、及OCF2X,其中n為自之整數,及 X為Η、Cl、或Br ;At least one of R10 to R19 is selected from the group consisting of F, 〇CnF2n + 1, and OCF2X, where n is an integer from X, and X is Η, Cl, or Br; R21至R30之至少一者係選自;ρ、c ρ2 〇CnF2n+1、及OCFJ,其中n為自之整 -4- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 8 8 8 8 ABCD 1238819 申請專利範圍 數,及X為Η、Cl、或Br。 6. 一種有機電子裝置,包括具有在57〇至7〇〇毫微米之範圍 内之發射最大值的發射層,其中發射層之至少2〇重量百 分比包括具有以下之第三化學式的至少—化合物: (第三化學式) IrLaLbLc 其中: a b 、L 、及L係彼此相似或不同,且各、Lb、及 L具有選自以下之結構及結構的結構: 其中 汉17、 Rl6 Ri〇4At least one of R21 to R30 is selected from the group consisting of ρ, c ρ2 〇CnF2n + 1, and OCFJ, where n is the integer since -4- This paper size applies the Chinese National Standard (CNS) A4 specification (210 X 297 mm) ) 8 8 8 8 ABCD 1238819 Number of patent applications, and X is Η, Cl, or Br. 6. An organic electronic device comprising an emission layer having an emission maximum in a range of 57 to 700 nanometers, wherein at least 20 weight percent of the emission layer includes at least a compound having a third chemical formula: (Third Chemical Formula) IrLaLbLc wherein: ab, L, and L are similar or different from each other, and each, Lb, and L have a structure selected from the following structures: wherein Han 17, Rl6 Ri04 (χτ) R10至Ri9之至少一者係選自F、CnF2n+i、 〇CnF2n+1、及0CF2X’其中n為自之整數,及 X為Η、Cl、或Br ;(χτ) at least one of R10 to Ri9 is selected from F, CnF2n + i, 0CnF2n + 1, and 0CF2X 'where n is an integer from and X is Η, Cl, or Br; (ΧΠ) 其中: 2n+ 1 R21至R3〇之至少一者係選自F、c F -5 - 本紙張尺度適用中國國家標準(CNS) A4規格(210x 297公釐) 1238819 έ88 C8 D8 六、申請專利範圍 〇CnF2n+1、及OCF2X,其中η為自1至6之整數,及 X為Η、C1、或Br。 7. 一種具有第六化學式之化合物,其係選自下所列化 合物9-a至9-1 : IrLaLbLfLM (第六化學式) 化合物 La 及 Lb L, L” Ri r2 R3 R4 r5 r6 Rt r8 9-a 結構(I) NC-1 氯化物 Η ch3 Η H F H F H 9-b 結構① NC-1 氯化物 Η Η ch3 H F H F H 9-c 結構(I) NC-1 氯化物 Η Η Η H F H F H 9-d 結構(I) NC-1 氯化物 Η Η Η H H cf3 H H 9-e 結構(I) NC-1 氯化物 Η ch3 Η H H cf3 H H 9-f 結構(I) NC-1 氯化物 Η Η cf3 H H H F H 9-g 結構(I) NC-1 氯化物 Η Η cf3 H H cf3 H H 9-h 結構(I) NC-2 氯化物 Η Η Η H H cf3 H H 9-i 結構(I) NC-3 氯化物 Η Η cf3 H H H F H 9-j 結構(I) PPh3 氯化物 Η Η cf3 H H H F H 9-k 結構(I) PtmPh3 氯化物 Η Η cf3 H H H F H 9-1 結構(I) CO 氯化物 Η Η cf3 H H H F H 其中: 結構(I)代表(ΧΠ) Among them: At least one of 2n + 1 R21 to R3〇 is selected from F, c F -5-This paper size is applicable to China National Standard (CNS) A4 specification (210x 297 mm) 1238819 172 88 C8 D8 VI. Application The patent scope is 0CnF2n + 1, and OCF2X, where η is an integer from 1 to 6, and X is Η, C1, or Br. 7. A compound having a sixth chemical formula, which is selected from the following compounds 9-a to 9-1: IrLaLbLfLM (sixth chemical formula) compounds La and Lb L, L "Ri r2 R3 R4 r5 r6 Rt r8 9- a Structure (I) NC-1 chloride Η ch3 Η HFHFH 9-b Structure ① NC-1 chloride Η ch3 HFHFH 9-c Structure (I) NC-1 chloride Η Η HFHFH 9-d Structure (I ) NC-1 chloride Η Η Η HH cf3 HH 9-e structure (I) NC-1 chloride Η ch3 Η HH cf3 HH 9-f structure (I) NC-1 chloride Η Η cf3 HHHFH 9-g structure (I) NC-1 chloride Η cf cf3 HH cf3 HH 9-h structure (I) NC-2 chloride Η Η Η HH cf3 HH 9-i structure (I) NC-3 chloride Η Η cf3 HHHFH 9- j Structure (I) PPh3 chloride Η cf3 HHHFH 9-k Structure (I) PtmPh3 chloride Η Η cf3 HHHFH 9-1 Structure (I) CO chloride Η Η cf3 HHHFH where: Structure (I) represents 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 1238819 申請專利範園 其中,A係C ; NC-1 係 2,6-(CH3)2C6H3NC ,· NC-2 係 3-CF3C6H4NC ; NC-3 係 4-CH3C6H4S02CH2NC ; PPh3 係 P(C6H5)3 ;及 8. PtmPh3 為(Arf)3p,其中 Arf H(CF3)2C6H3。 -種有機電子裝置,包括具有在45()至5⑼亳微米之範圍 内之發射最大值的發射層,其中發射層之至少2〇重量百 分比包括具有以下之第六化學式的至少一化合物: IrLaLbL,L, (第六化學式) 其中: LW系選自膦、異腈、及一氧化碳; L”係選自F、cn、Br、及I ; 1/及1^具有以下的結構, 0) R4 其中 1至1係分別選自烷基、烷氧基、鹵素、硝基、氰 基、氟基、氟化烷基及氟化烷氧基,及心至!^ 本紙張尺度適用中國國家標準(CNS) A4規格(210X297公釐) 1238819 A8 B8 C8 D8 申請專利範圍 之至少一者係選自F、CnF2n+i、OCnF2n+i、及 OCF2X,其中n為自1至6之整數,及X為Η、 Cl 、或Br ,及 A為C 〇 9.根據申請專利範圍第8項之裝置,其中L”為C1,及L,係選 自三苯膦、參[3,5-雙(三氟甲基)苯基]膦、異氰2,6-二甲 苯、異氰3-三氟甲苯、及異氰4-甲苯磺醯甲烷。 10·根據申請專利範圍第8項之裝置,其中該化合物係選自根 據申請專利範圍第7項之化合物。 H· 一種具結構(II)之化合物,其係選自下所列化合物 至 12j :This paper size applies to China National Standard (CNS) A4 specification (210 X 297 mm) 1238819 Patent application park, where A is C; NC-1 is 2,6- (CH3) 2C6H3NC, · NC-2 is 3- CF3C6H4NC; NC-3 is 4-CH3C6H4S02CH2NC; PPh3 is P (C6H5) 3; and 8. PtmPh3 is (Arf) 3p, of which Arf H (CF3) 2C6H3. -An organic electronic device comprising an emission layer having an emission maximum in a range of 45 (5) to 5 μm, wherein at least 20 weight percent of the emission layer includes at least one compound having the sixth chemical formula: IrLaLbL, L, (sixth chemical formula) wherein: LW is selected from the group consisting of phosphine, isonitrile, and carbon monoxide; L "is selected from the group consisting of F, cn, Br, and I; 1 / and 1 ^ have the following structures, 0) R4 where 1 To 1 series are selected from the group consisting of alkyl, alkoxy, halogen, nitro, cyano, fluoro, fluorinated alkyl and fluorinated alkoxy, respectively. ^ This paper size applies to Chinese National Standards (CNS) A4 specifications (210X297 mm) 1238819 A8 B8 C8 D8 At least one of the patent application scopes is selected from F, CnF2n + i, OCnF2n + i, and OCF2X, where n is an integer from 1 to 6, and X is Η, Cl, or Br, and A are C. 9. The device according to item 8 of the scope of the patent application, wherein L "is C1, and L is selected from triphenylphosphine, ginseng [3,5-bis (trifluoromethyl) ) Phenyl] phosphine, isocyanate 2,6-xylene, isocyanate 3-trifluorotoluene, and isocyanate 4-toluenesulfonylmethane. 10. The device according to item 8 of the scope of patent application, wherein the compound is selected from the compounds according to item 7 of the scope of patent application. H. A compound of structure (II), which is selected from the following compounds to 12j: 化合物 A Ri r2 Rs R4 Rs Λβ__ r7 R〇 Rn 12-a C H ch3 H H H H F '"Ο H H 12-b C H ch3 H H H H cf3 XI H 12-c c H H ch3 H F H F H H 12-d c H ch3 H H H H H H 12-e c H H ch3 H H H cf3 丄i H _J2-f c H H H H H H H X X H c H H H H F H F H X X H 本紙張尺度適用巾國國家標準(CNS) Μ規格(别χ 297公爱) 1238819 A8 B8 C8 D8 六、申請專利範圍 12-h C H t-Bu H H H H F H H 12-i C H t-Bu H H H cf3 H cf3 H 12-j c H ch3 H H H H cf3 H H -9 - 本紙張尺度適用中國國家標準(CNS) A4規格(210X 297公釐)Compound A Ri r2 Rs R4 Rs Λβ__ r7 R〇Rn 12-a CH ch3 HHHHF '" 〇 HH 12-b CH ch3 HHHH cf3 XI H 12-cc HH ch3 HFHFHH 12-dc H ch3 HHHHHH 12-ec HH ch3 HHHH cf3 Hi H _J2-f c HHHHHHHHXXH c HHHHFHFHXXH This paper size is applicable to national national standards (CNS) M specifications (other 297 public love) 1238819 A8 B8 C8 D8 VI. Application scope 12-h CH t-Bu HHHHFHH 12 -i CH t-Bu HHH cf3 H cf3 H 12-jc H ch3 HHHH cf3 HH -9-This paper size applies to China National Standard (CNS) A4 (210X 297 mm)
TW90133244A 2001-06-12 2001-12-31 Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds TWI238819B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/879,014 US20020121638A1 (en) 2000-06-30 2001-06-12 Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds

Publications (1)

Publication Number Publication Date
TWI238819B true TWI238819B (en) 2005-09-01

Family

ID=37001113

Family Applications (1)

Application Number Title Priority Date Filing Date
TW90133244A TWI238819B (en) 2001-06-12 2001-12-31 Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds

Country Status (1)

Country Link
TW (1) TWI238819B (en)

Similar Documents

Publication Publication Date Title
JP4299144B2 (en) Electroluminescent iridium compounds comprising fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines, and devices made using such compounds
US6670645B2 (en) Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds
US7276726B2 (en) Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds
AU2001271550B2 (en) Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds
US20050186447A1 (en) Electroluminescent iridium compounds with phosphinoalkoxides and phenylpyridines or phenylpyrimidines and devices made with such compounds
EP2336142A2 (en) Iridium organic complex and electroluminescent device using same
AU2001271550A1 (en) Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds
US20040075096A1 (en) Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds
TWI238819B (en) Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds
KR100871275B1 (en) Electroluminescent iridium compounds with fluorinated phenylpyridines and devices made with such compounds
AU2002231155A1 (en) Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds
KR20080081209A (en) Fluorinated phenylpyridine compounds

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees